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 i 
Abstract 
Neisseria gonorrhoeae is the causative organism of the sexually transmitted 
infection (STI), gonorrhoea. Over decades of antibiotic use, the emergence of 
antibiotic-resistant strains of N. gonorrhoeae has dramatically increased and we are 
facing the reality of almost untreatable gonorrhoea. Combined with increasing 
incidence, there is an urgent need for new antimicrobial treatments for gonorrhoea 
infection. The synthesis of the amino acid cysteine is a promising new target for the 
development of new antimicrobials. Cysteine plays an important role in protein 
molecules, but also in the synthesis of glutathione for protection against oxidative 
stress. In addition, cysteine is the key step for the incorporation of sulphur into a 
variety of cellular constituents. N. gonorrhoeae displays unique differences in 
assimilation of sulphate for the synthesis of cysteine, yet little is known about the 
synthesis of this important amino acid in N. gonorrhoeae.  
The first step in the dual-step cysteine biosynthesis pathway is catalysed by the 
serine acetyltransferase, CysE, an essential gene in N. gonorrhoeae. To design 
inhibitors against this key enzyme we need to elucidate the enzymatic mechanism 
and the three-dimensional structure. In this thesis, we determine the kinetic 
parameters and regulation of CysE and present the structure of CysE to 2.01 Å. 
Biochemical assays demonstrate that CysE has serine acetyltransferase activity and 
experiences substrate inhibition by acetyl CoA. CysE is also sensitive to feedback 
inhibition by L-cysteine, which competitively inhibits CysE relative to the substrate 
L-serine. The structure shows CysE belongs to the left-handed β helix family and 
adopts a hexameric structure consisting of a dimer of trimers. Our structure reveals 
the first evidence of domain swapping for a CysE structure, where C-terminal tails 
domain swap with neighbouring monomers in the crystal lattice. Although an 
artefact of crystallisation it provides insight into the flexibility of this region.  
Collectively the data presented in this thesis represents key advances in our 
understanding of the uncharacterised cysteine biosynthetic pathway in 
N. gonorrhoeae. Data presented here is the basis for future work using the structure 
of CysE to guide computational inhibitor design, to identify lead compounds for 
CysE inhibition, and for the development of new antimicrobials for treatment of 
gonorrhoea.  
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1 Chapter 1 
Introduction 
1.1 Introduction 
Gonorrhoea is a sexually transmitted infection (STI), caused by the bacterial 
pathogen Neisseria gonorrhoeae (WHO, 2017; Wi et al., 2017). N. gonorrhoeae is 
a gram-negative diplococcus and is spread primarily through sexual contact. In 
2016, it was estimated that there were over 85 million cases of gonorrhoea, making 
it the second most prevalent STI worldwide (Rowley et al., 2019). Since the 
introduction of antibiotics in the 1940s, N. gonorrhoeae has acquired resistance to 
every single antibiotic used for its treatment. This rapid emergence of antibiotic 
resistance has created a demand for new antimicrobial treatments, to be able to 
effectively treat this disease in the future. Targeting amino acid synthesis is a new 
and promising route for the design of new antimicrobial drugs. The synthesis of the 
amino acid cysteine is one such route, not only is cysteine an important amino acid 
for protein function, cysteine synthesis is the primary pathway for the assimilation 
of sulphur in bacterial cells. However, the cysteine biosynthesis pathway is 
uncharacterised in N. gonorrhoeae. This research investigates the key enzyme for 
cysteine biosynthesis, CysE, as a potential drug target in N. gonorrhoeae. 
1.2 Gonorrhoea pathogenesis  
N. gonorrhoeae is an obligate human pathogen that has evolved with humans over 
millennia. One of the key successes of N. gonorrhoeae pathogenicity is its ability 
to mitigate host immune defences. N. gonorrhoeae infects mucosal surfaces with 
the most common site of gonorrhoea infection being the urogenital tract (Wi et al., 
2017). However, N. gonorrhoeae infection is also commonly found in the anus, 
nasopharynx and eyes of new born babies whose mothers have been infected with 
gonorrhoea (Sandstrom, 1987). Gonorrhoeal infection begins with the colonising 
of the mucosal membrane. N. gonorrhoeae adheres to the surface of epithelial cells 
type via their Type IV pili and opacity (Opa) adhesion like proteins (Edwards & 
Butler, 2011). The bacteria are internalised into the epithelial cell by endocytosis 
(Merz & So, 2000; Quillin & Seifert, 2018). N. gonorrhoeae then traffics across the 
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epithelial cell layer and exits at the basolateral end where it is subsequently detected 
by the immune system (Billker et al., 2002). This prompts immune activation and 
a localised inflammatory response, mainly a large influx of neutrophils leading to 
the development of symptoms characteristic of gonorrhoea infection (Hill et al., 
1985; Ramsey et al., 1995). However, in a large number of cases gonorrhoeal 
infection is asymptomatic but still transmissible, with women disproportionally 
affected compared to men (50 vs.10%) (Workowski & Berman, 2010), leading to 
persistent gonorrhoeal infection. If left untreated N. gonorrhoeae can ascend to the 
upper urogenital tract, which can lead to serious complications including infertility 
and pelvic inflammatory disease (Haggerty & Ness, 2006; Stevens & Criss, 2018), 
and in rare cases disseminate throughout the body causing arthritis (Masi & 
Eisenstein, 1981). Infection of the nasopharynx is also asymptomatic but 
transmissible via oral sex (Fifer et al., 2018), but perhaps of more concern is that 
infection of the nasopharynx is hypothesised to be one of the main routes for 
acquisition of antimicrobial-resistant genes (Unemo & Nicholas, 2012). Neisseria 
species are naturally transformable and readily obtain DNA from the environment 
and integrate this into the chromosome (Ochman et al., 2000). This natural 
transformability also plays a role in the generation of antigenic variation, preventing 
the immune system from being able to recognise the pathogen and allowing people 
to experience multiple gonorrhoea infections over their lifetime (Stern et al., 1986; 
Criss et al., 2005). 
1.3 The emergence of antimicrobial-resistant Neisseria 
gonorrhoeae 
The rapid emergence of antibiotic-resistant strains of N. gonorrhoeae has led to 
N. gonorrhoeae being labelled a high priority pathogen by the World Health 
Organisation (WHO) (WHO, 2017). Out of all STIs, N. gonorrhoeae has the highest 
levels of antibiotic resistance. Over decades of antibiotic use, N. gonorrhoeae has 
developed resistance to an extensive range of antibiotic classes including; 
sulphonamides, penicillins, tetracyclines, fluoroquinolones, macrolides and 
cephalosporins (Figure 1.1) (Unemo & Shafer, 2014; Wi et al., 2017). 
The United States (US) Centre for Disease Control and Prevention (CDC), 
recommends dual antibiotic use to help combat the rise of resistance. The current 
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recommended dual-therapy is the oral antibiotic azithromycin and the injectable 
extended-spectrum cephalosporin (ESC), ceftriaxone (Heffernan et al., 2015; Wi et 
al., 2017; Fifer et al., 2018; Weston et al., 2018). However, even with dual-therapy, 
frontline antibiotic-resistant strains have emerged both globally and locally (Wi et 
al., 2017; Eyre et al., 2018; Lee et al., 2018). 
 
Figure 1.1: Timeline of the emergence of antibiotic-resistant gonorrhoea. Figure from (CDC, 2016).  
On a global scale, antibiotic resistance to azithromycin and ceftriaxone are on the 
rise (Unemo & Shafer, 2014; Fifer et al., 2018; George et al., 2019) and 
N. gonorrhoeae has now achieved ‘super-bug’ status (WHO, 2017). In 2018, strains 
in the UK were isolated that were completely resistant to both azithromycin and 
ceftriaxone (Eyre et al., 2018; Jennison et al., 2019). These patients required 
hospitalisation for three days for treatment with last resort intravenous antibiotics. 
While there have been no cases of treatment-resistant gonorrhoea in New Zealand, 
resistance to azithromycin and ceftriaxone have been detected in several district 
health boards (Lee et al., 2018; ESR, 2019). A recent study tested the antimicrobial 
susceptibility of 400 New Zealand N. gonorrhoeae isolates and demonstrated that 
around 10 and 4% of isolates, displayed decreased susceptibility to azithromycin 
and ceftriaxone, respectively (Lee et al., 2018). Combined with increasing global 
incidence rates of gonorrhoea, there is a very real possibility that azithromycin and 
ceftriaxone-resistant gonorrhoea will be encountered in New Zealand. 
Subsequently, N. gonorrhoeae has been titled a ‘high priority pathogen’ by the 
WHO with research desperately needed to develop vaccines to reduce the spread of 
gonorrhoea, and new treatments for antimicrobial-resistant gonorrhoea infections 
(WHO, 2017). We need new antimicrobial targets for the design of new antibiotics. 
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Once such approach is through targeting pathways and mechanisms that are 
essential for infection and survival of N. gonorrhoeae.  
One new and promising area of antimicrobial research is targeting amino acid 
biosynthesis pathways (Campanini et al., 2015). The sulphur assimilation and 
cysteine biosynthetic pathways have been investigated for development of 
antimicrobials for treatment of persistent pathogens, such as the tuberculosis 
causing bacterium, Mycobacterium tuberculosis, and we hypothesise these are also 
a valid target in N. gonorrhoeae. 
1.4 Oxidative stress and the role of L-cysteine in the cell 
L-cysteine is the primary method of making environmental sulphur available to the 
cell. Cysteine is used to make a host of vital biomolecules such as iron-sulphur 
cluster proteins, biotin and co-enzyme A (Kredich, 2008). Cysteine is also required 
for reducing agents, including thioredoxin and glutathione, which are essential for 
mitigating intracellular oxidants (Carmel-Harel & Gisela., 2000; Kredich, 2008).   
One of the main challenges for bacteria, in particular pathogens, is evasion of the 
host immune system and mitigation of the hostile host environment, which is where 
N. gonorrhoeae excels (Quillin & Seifert, 2018). N. gonorrhoeae encounters two 
major sources of oxidative stress; oxidative stress produced by commensal 
Lactobacillus species, and the host immune system. The immune system exerts this 
primarily through polymorphonuclear neutrophils (PMNs) (Seib et al., 2006).  
Lactobacilli are one of the predominant commensals of the female urogenital tract 
(Eschenbach et al., 1989). Lactobacillus species have been shown to prevent the 
colonisation of N. gonorrhoeae (Eschenbach et al., 1989). Lactobacillus species 
secrete hydrogen peroxide, which in turn inhibits growth of N. gonorrhoeae (St 
Amant et al., 2002). Lactobacilli also secrete lactate, which lowers pH and 
promotes aerobic respiration, leading to the endogenous production of reactive 
oxygen species (ROS) (Seib et al., 2006).  
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In gonorrhoea infection, one of the main oxidative challenges is from the host 
immune system. During colonisation of the surface of the cell epithelia, outer 
membrane vesicles (OMVs) and lipooligosaccharide (LOS) are released by 
N. gonorrhoeae, and bind to nucleotide-binding oligomerisation domain (NOD) 
and toll-like receptors (TLRs) on dendritic cells and macrophages (Liu et al., 2006). 
This binding triggers the release of chemokines and cytokines (Kawasaki & Kawai, 
2014). The release of cytokines recruits PMNs to the site of infection (Borregaard, 
2010). Here, PMNs phagocytose N. gonorrhoeae, which are exposed to large 
amounts of oxidative stress from the neutrophil mediated oxidative burst (rapid 
release of ROS) (El-Benna et al., 2016). While phagocytosis is an effective method 
for killing bacteria, N. gonorrhoeae has evolved the ability to survive this process 
and hijack these PMNs (Simons et al., 2005). The purulent exudate typical of 
symptomatic gonorrhoea infection, largely consists of PMNs infected with N. 
gonorrhoeae (Hill et al., 1985). For N. gonorrhoeae to be able to mitigate this 
oxidative stress would require effective intracellular reducing systems, and for the 
most part, the compounds that make up these systems are derived from L-cysteine. 
Glutathione is derived from L-cysteine and is synthesised by glutathione reductase. 
Glutathione’s role in the cell is to scavenge free radicals and prevent unwanted 
oxidation of the cellular contents (Meister & Anderson, 1983). Glutathione levels 
are one of the main mechanisms to mitigate oxidative stress encountered during 
infection. Glutathione levels have been reported to be three-fold greater in 
N. gonorrhoeae compared to E. coli (15 vs. 5 mM) (Archibald & Duong, 1986). 
Glutathione synthesis systems are present in N. gonorrhoeae (Hicks & Mullholland, 
2018), but the bacteria lack glutathione transportation systems (Seib et al., 2006). 
Given that there are no transporters present, glutathione synthesis is reliant on the 
cysteine biosynthesis pathway (Hicks & Mullholland, 2018).  
1.5 Sulphate import, reduction and cysteine biosynthesis in 
Neisseria species 
The de novo biosynthesis of L-cysteine is conserved across both bacterial and 
higher plant species. This is the predominant pathway for making inorganic sulphur 
available to the organism. There is a large degree of genome similarity between 
Neisseria meningitidis and N. gonorrhoeae (90%) (Hicks & Mullholland, 2018), 
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however there are key differences in terms of sulphate assimilation and cysteine 
synthesis, between these pathogenic Neisseria species, which will be addressed in 
this section. 
1.5.1 Active transport of sulphate 
Cysteine biosynthesis begins with the importation and successive reduction of 
sulphate inside the cell. There are two main classes of sulphate transporter proteins, 
the major facilitator superfamily (MFS) and ATP-binding cassette (ABC) 
superfamily (Guédon & Martin-Verstraete, 2007). Sulphate is actively imported 
into the cell by these transporters. In pathogenic Neisseria species (N. meningitidis 
and N. gonorrhoeae), genomic analysis showed that N. gonorrhoeae possesses only 
one sulphate uptake system, belonging to the ABC transporter superfamily (Figure 
1.2) (Hicks & Mullholland, 2018). This is composed of a transporter permease 
(cysW), an ATP-binding protein (cysA), periplasmic sulphate-binding protein (sbp) 
and a sulphate permease (cysU) (Kertesz, 2001; Hicks & Mullholland, 2018). cysU 
is present in both pathogenic Neisseria species except for N. gonorrhoeae strain 
FA1090 (Hicks & Mullholland, 2018). Previous research has shown that the sbp 
transporter is able to transport sulphate (Kredich, 2008) and given that 
N. gonorrhoeae is able to grow on thiosulphate as a sole sulphur source (Le Faou, 
1984), this suggests that sbp is able to transport thiosulphate in N. gonorrhoeae 
(Hicks & Mullholland, 2018).  
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Figure 1.2: Sulphate assimilation and cysteine biosynthetic pathways in Neisseria species. Sulphate 
importation and reduction pathway (red) is non-functional in N. gonorrhoeae. Both pathways are 
functional in N. meningitidis. Figure from (Hicks & Mullholland, 2018).Reduction of 
sulphate  
Once imported into the cell, sulphate is primed for incorporation into L-cysteine 
through successive reduction to sulphide (Figure 1.2). In E. coli, sulphate is initially 
reduced to adenosine 5'-phosphosulphate (APS) by the multi-enzyme complex ATP 
sulfhydrylase (cysDN). For the majority of bacteria, APS is reduced to 
phosphoadenosylphosphosulphate (PAPS) by ATP-kinase (cysC), and then is 
reduced by PAPS reductase (cysH), to sulphite and phosphoadenosylphosphate 
(PAP) (Kredich, 2008). Uniquely, in Neisseria both reactions are carried out by a 
single enzyme, APS reductase (also denoted as cysH), which reduces APS directly 
to sulphite (Figure 1.2) (Rusniok et al., 2009). The final step in the sulphate 
reduction pathway is the reduction of sulphite to sulphide, by sulphite reductase 
(cysIJ) (Kredich, 2008). Sulphide is then incorporated with O-acetylserine to form 
L-cysteine.  
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Analysis of Neisseria genomes revealed that the completeness and arrangement of 
the sulphate reduction pathway varies (Hicks & Mullholland, 2018). In 
N. meningitidis, the genes for both import and reduction of sulphate are controlled 
under a single operon cysGHDNJI. In all N. gonorrhoeae strains examined, a 3.5 kb 
deletion between genes cysG and cysN is present, removing cysH and cysD from 
the operon (Figure 1.3) (Hicks & Mullholland, 2018). These genes are not found 
elsewhere in the N. gonorrhoeae genome (Hicks & Mullholland, 2018). The genes 
cysIJ, encoding the sulphite reductase are present in the N. gonorrhoeae genome, 
but are non-functional due to an in-frame stop codon present in each coding 
sequence (Figure 1.3). The deletion of cysD and cysH would prevent the ability 
N. gonorrhoeae to reduce sulphate and the in frame stop codons in cysIJ would 
prevent the reduction of sulphite to sulphide rendering this pathway non-functional 
in N. gonorrhoeae. Previous research by Le Faou (1984), investigated the sulphur 
requirements of pathogenic Neisseria, and demonstrated that N. gonorrhoeae is 
unable to grow on sulphate as the sole source of sulphur. This is consistent with the 
non-functional sulphate reduction pathway in N. gonorrhoeae described above and 
differs from commensal Neisseria species and N. meningitidis which can grow on 
sulphate as a sole sulphur source. Previous growth experiments  demonstrated that 
N. gonorrhoeae can grow on media supplemented with thiosulphate, in the absence 
of L-cysteine (Le Faou, 1984), which suggests that the ABC transporter complex is 
able to import both thiosulphate and sulphate (Hicks & Mullholland, 2018). 
 
 
Figure 1.3: Comparison of sulphate reduction operons in Neisseria species. Dotted lines represent 
a deletion between cysG and cysN in N. gonorrhoeae, which results in the deletion of cysH and cysD 
and the partial truncation of cysG and cysN. Direction of arrows indicate direction of transcription. 
Dashed lines represent areas of homology. Figure from (Hicks & Mullholland, 2018). 
1.5.3 Transport of L-cysteine and L-cystine 
While de novo cysteine synthesis is well conserved across bacteria, bacteria can 
also obtain L-cysteine directly from the environment.  Under oxidative conditions, 
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the majority of L-cysteine will be in its oxidised form L-cystine (two L-cysteine 
molecules connected by a disulphide bond) (Ohtsu et al., 2010). In Neisseria 
species, L-cysteine and L-cystine are actively imported into the cell via 
ABC-transporters. N. gonorrhoeae has ABC transporters for both L-cysteine 
(ngo2011-2014), and L-cystine (ngo0372-0374) (Bulut et al., 2012; Hicks & 
Mullholland, 2018). Interestingly, homology searches of the N. meningitidis 
genome revealed the presence of only the L-cystine transporter. Comparison of the 
N. gonorrhoeae and N. meningitidis genomes (90% sequence homology), revealed 
the complete deletion of the L-cysteine ABC transporter operon (Figure 1.4) from 
N. meningitidis. Further searching demonstrated that these genes were not present 
elsewhere in the N. meningitidis chromosome (Hicks & Mullholland, 2018). This 
suggests N. meningitidis either relies on L-cystine and de novo cysteine synthesis 
to meet L-cysteine demands, or has a different transporter for L-cysteine (Hicks & 
Mullholland, 2018). This difference might be due to differences in cysteine/cysteine 
availability, between the host infections sites of N. gonorrhoeae and N. meningitidis.   
Across bacteria, the ability to import L-cysteine and L-cystine is well conserved, 
particularly in pathogens. The advantage of being able to import L-cysteine/L-
cystine from the environment, is it requires less energy compared to de novo 
synthesis of L-cysteine (Takahashi et al., 2018). However, transportation alone 
would not be ideal in a cysteine/cystine deplete or oxidative environment, and 
therefore justifies the need for de novo synthesis of L-cysteine. 
 
Figure 1.4: Comparison of L-cysteine and L-cystine transporters in pathogenic Neisseria species. 
L-cystine transporter operons are present in both Neisseria species. L-cysteine ABC transporter 
operon is only present for N. gonorrhoeae and not in N. meningitidis. Direction of arrows indicate 
direction of transcription. Dashed lines represent areas of homology. Figure from (Hicks & 
Mullholland, 2018).  
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1.5.4 Cysteine biosynthesis  
The cysteine biosynthesis pathway is a two-step reaction, catalysed by serine 
acetyltransferase (SAT) and O-acetylsulfhydrylase (OASS), which have been 
denoted as CysE and CysK/CysM (isoforms of OASS), respectively. CysE 
catalyses the acetylation of L-serine, forming O-acetylserine and CoA. Finally, 
O-acetylserine undergoes a condensation reaction, catalysed by CysK with sulphide 
to form L-cysteine (Figure 1.5). The two-step pathway is regulated at the first step 
by feedback inhibition with L-cysteine (Figure 1.5).  
 
Figure 1.5: CysE and CysK reaction pathway for cysteine biosynthesis. Red line demonstrates 
cysteine feedback inhibition of CysE. Figure adapted from (Yi et al., 2013). 
CysE is a member of the left-handed β helix family and is well conserved across 
bacteria (Johnson et al., 2005). CysE is an essential gene in N. gonorrhoeae 
(Remmele et al., 2014) and while is non-essential in N. meningitidis, the cysE 
deletion strain grows poorly in media and has increased sensitivity to antibiotics 
(Capel et al., 2016). The primary method of preventing high concentrations of 
L-cysteine, which is toxic to bacteria, is via feedback inhibition of CysE, a 
mechanism which is also well conserved across bacteria (Johnson et al., 2004; 
Benoni et al., 2017b). 
There are two isoforms of O-acetylsulfhydryalase, OASS-A and OASS-B, which 
have been denoted as CysK and CysM, respectively (Kredich, 2008). OASS belong 
to the cysteine synthase superfamily and utilises pyridoxal 5’-phosphate (PLP) as a 
cofactor. In S. typhimurium, both OASS isoforms are present, but CysM was shown 
to be expressed under anaerobic conditions, while CysK expressed under aerobic 
conditions (Tai et al., 1993). CysM differs from CysK as it able to directly utilise 
thiosulphate to create S-sulfocysteine (Tai et al., 1993), which is then reduced to 
L-cysteine. Most bacteria have both CysK (OASS-A) and CysM (OASS-B) 
isoforms for the synthesis of cysteine using sulphide or thiosulphate respectively. 
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Neisseria species are unique in that they have only one OASS isoform with greatest 
homology to CysK (OASS-A), that utilises sulphide for the synthesis of cysteine 
(Hicks & Mullholland, 2018). This raises interesting questions regarding the role 
of CysK in N. gonorrhoeae, as the bacterium lacks the ability to reduce sulphate to 
sulphide and relies on thiosulphate for the synthesis of cysteine, a substrate that is 
usually used by the alternate OASS isoform CysK. While OASS is not an essential 
gene for pathogenic Neisseria species (Remmele et al., 2014), it has been shown to 
be important for cell invasion in N. meningitidis (Capel et al., 2016). 
1.6 Regulation of cysteine biosynthesis 
1.6.1 The cysteine synthase complex 
The flux of sulphur through the cysteine biosynthesis pathway is regulated at the 
protein level in two ways: feedback inhibition by the pathway product, L-cysteine, 
and the formation of the cysteine synthase complex (CSC). This bienzyme complex 
was first discovered during purification of CysE and CysK from S. typhimurium 
(Kredich & Tomkins, 1966; Kredich et al., 1969). Evidence of CSC formation has 
been confirmed in bacterial species, including E. coli (Mino et al., 1999; Benoni et 
al., 2017b) and Haemophilus influenzae (Salsi et al., 2010), as well as plants (Yi et 
al., 2013). Gel filtration chromatography and fluorometric studies have 
demonstrated that the stoichiometry of the CSC is composed of a 3:2 protomer ratio, 
consisting of one CysE hexamer and two dimers of CysK (Figure 1.6) (Kredich et 
al., 1969; Wang & Leyh, 2012; Benoni et al., 2017b). The C-terminal tail of CysE 
inserts into the active site of CysK to inhibit its activity.  
 
 
 
 
 
Chapter 1 
 
12 
The formation of the CSC is ultimately controlled by sulphur availability. As a part 
of the CSC, CysE loses sensitivity to inhibition by L-cysteine, and catalytic activity 
increases as a result of reduction of substrate inhibition by L-serine (Benoni et al., 
2017b). Contrastingly, in the CSC, CysK activity becomes almost completely 
inhibited (Saito et al., 1995). The CSC is dissociated by millimolar amounts of 
CysE product O-acetylserine (Kredich et al., 1969; Wang & Leyh, 2012) O-
acetylserine can then non-enzymatically isomerise, forming N-acetylserine, which 
can bind to transcriptional regulator CysB and promote expression of sulphate 
assimilatory genes, but when sulphur is available, sulphide promotes association of 
the CSC (Droux et al., 1998; Zhao et al., 2006). Hence, the CSC acts as form of 
regulation in response to sulphur availability in the environment.  
The binding of the CysE C-terminal peptide into the active site of CysK has been 
confirmed through fluorometric spectroscopy peptide binding studies, which 
monitored a blue shift in emission (500 nm) by CysK co-factor, pyridoxal 5’-
phosphate (PLP) (Campanini et al., 2005). The complex has also been shown to 
protect CysE from cold inactivation and proteolytic degradation (Mino et al., 2001). 
Combined, the CSC is an important regulatory element of the cysteine biosynthetic 
pathway and to date is uncharacterised in N. gonorrhoeae. 
 
Figure 1.6: Analysis of the cysteine synthase complex from E. coli. (a) Example of gel filtration 
chromatograph of CSC, CysE and CysK. (b) Formation of the CSC through monitoring PLP 
emission at 500 nm with increasing [CysE/CysK] molar ratio. Figure adapted from (Benoni et al., 
2017b). 
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There is no structure of the CSC to date, however there is crystal structure of CysK 
from H. influenzae, with a ten amino acid CysE C-terminal peptide bound in the 
active site (Huang et al., 2005). Exploration of the key residues required for binding 
was determined by screening a tetrapeptide library, where binding ability was 
monitored by CysK activity and PLP fluorescence (Campanini et al., 2005). The 
authors demonstrated that a C-terminal isoleucine is essential for binding and 
inhibition of CysK. This residue has been shown to be well conserved across CSC 
forming organisms (Huang et al., 2005; Salsi et al., 2010; Benoni et al., 2017b). 
Using Clustal Omega (Madeira et al., 2019) we generated a sequence alignment of 
five sequences for bacterial CysE homologues and were analysed using ESPript 3.0 
(Figure 1.7)(Robert & Gouet, 2014). CysE from N. gonorrhoeae shows moderate 
sequence similarity to the compared CysE homologues (57%, with the exception of 
N. meningitidis, 97%). Here we see that the C-terminus four peptide fragment, 
GDGI, is well conserved between Yersinia pestis, E. coli and S. typhimurium. In 
Neisseria species this peptide sequence is DFMI.  Due to conservation of the C-
terminal isoleucine we expect CysE from N. gonorrhoeae to form the CSC. Given 
that there are key differences in the sulphate assimilation pathways between N. 
gonorrhoeae and other bacteria, characterisation of the CSC would provide further 
insight into sulphur assimilation and synthesis of L-cysteine in N. gonorrhoeae.  
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Figure 1.7: CysE peptide sequence alignment. The N. gonorrhoeae FA1090 CysE peptide sequence 
was aligned to the following CysE homologues; N. meningitidis (97% sequence similarity); 
H.  influenzae (54.8% sequence similarity); Y. pestis (57% sequence similarity); E. coli (57.4% 
sequence similarity) and S. typhimurium (57% sequence similarity). Highly conserved residues are 
highlighted in red, and less conserved residues are highlighted in yellow. Active site residues for 
CysE are surrounded by a blue box. Example of hexapeptide repeat highlighted in black box. The 
last ten residues of C-terminal tail are surrounded by a green box. Sequence alignment created using 
Clustal Omega. Figure created using ESPript 3 (Robert & Gouet, 2014). 
1.6.2 Transcriptional regulation of sulphate assimilation and cysteine 
biosynthesis  
Transcriptional regulation of the cysteine regulon is controlled by the master 
regulator CysB. CysB is a tetramer and a member of the LysR family of 
transcription factors (Henikoff et al., 1988). Within the CysB N-terminal domain is 
a helix-turn-helix motif which allows DNA binding (Pabo & Sauer, 1984). CysB 
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positively regulates the sulphate assimilatory and cysteine synthesis genes, in the 
presence of cysteine pathway intermediate, N-acetylserine (isoform of 
O-acetylserine) (Ostrowski & Kredich, 1989; Hryniewicz & Kredich, 1991). The 
CysE product O-acetylserine is unstable and rapidly and non-enzymatically forms 
the isoform N-acetylserine. The proposed mechanism for CysB-mediated activation 
is binding of N-acetylserine produces a conformational change in CysB, which then 
binds to CysB binding regions and recruits RNA polymerase (Hicks & Mullholland, 
2018). Investigation of CysB regulation in S. typhimurium demonstrated that CysB 
upregulated expression of sulphate assimilation genes cysJIH, cysK and cysP 
(Ostrowski & Kredich, 1989). CysB also negatively autoregulates its own 
transcription through binding upstream of its own promoter (Jagura-Burdzy & 
Hulanicka, 1981; Ostrowski & Kredich, 1991).  Hicks and Mullholland (2018) 
identified the presence of the DNA binding repeat for CysB (CCGTTG-N17-
CAACGG) in the cysB promoter region in both N. gonorrhoeae and N. meningitidis. 
However, these binding sites could not be confirmed at the start of the sulphate 
reduction regulon or cysteine biosynthetic genes in N. gonorrhoeae. This could be 
due low conservation of CysB binding sequences.  
cysB is an essential gene in N. gonorrhoeae (Remmele et al., 2014). During in vivo 
infection, cysB expression was downregulated compared to growth on media 
(McClure et al., 2015). Transcriptional regulation of the cysteine regulon is 
particularly important for pathogenic bacteria, as the success of infection is 
dependent on the ability of the organism to rapidly adapt to and overcome host 
defences. The only gene in the sulphate assimilation and cysteine biosynthesis 
regulon not under CysB transcriptional regulation is cysE, which is constitutively 
expressed (Jones-Mortimer et al., 1968; Kredich, 1971). However, CysE 
experiences regulation at the enzyme level, with feedback inhibition by L-cysteine 
and formation of cysteine synthase complex. 
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1.7 CysE 
1.7.1 Structural characteristics of CysE  
The serine acetyltransferase (SAT), CysE, belongs to the left-handed parallel 
β-helix (LβH) family. LβH proteins are defined by a hexapeptide tandem repeat, 
consisting of [LIV]-[GAED]-X2-[STAV]-X, that gives rise to a left handed β-barrel, 
which is a unique structural feature of these proteins (Raetz & Roderick, 1995). 
SATs are composed of two structural domains: an amino-terminal (N-terminal) α-
helical domain and an LβH carboxyl-terminal (C-terminal) domain. The LβH 
domain is structured like triangular prism, which fit with two other monomers, to 
form a trimer (Johnson et al., 2005). The resulting trimer dimerises to forms a 
hexamer through hydrophobic interactions at the N-terminal face of each trimer 
(Pye et al., 2004). SATs are unique as they are the only acyltransferase to adopt a 
hexameric conformation, instead of the more common trimeric arrangement 
(Johnson et al., 2005). This higher oligomeric state allows for pathway regulation 
through formation of the CSC (Mino et al., 1999; Wirtz & Hell, 2006; Benoni et 
al., 2017b), which has been shown to not form in a rare trimeric form of SAT from 
Entamoeba histolytica (Kumar et al., 2011). 
To date there are only six bacterial CysE structures deposited in the Protein Data 
Bank (PDB). Independent of sequence similarity there is good structural 
conservation between bacterial and plant CysE proteins (Olsen et al., 2004; Yi et 
al., 2013). Structures include CysE in the apo, L-serine (substrate), CoA (product) 
and L-cysteine (inhibitor) bound forms (Figure 1.8). Both L-serine and L-cysteine 
bind in the bottom of the CysE active site, above the extended β-loop. Comparison 
of structures with L-serine and CoA bound, demonstrates that the thioester group 
from CoA is in close proximity to L-serine bound in the active site, supporting the 
proposed mechanism of serine acetyltransferases.  
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The C-terminal tail of the CysE monomer that binds to CysK to form the CSC has 
also been implicated in L-cysteine inhibition. Deletion of the C-terminal tail  
reduces L-cysteine sensitivity (increased Ki for L-cysteine) (Mino et al., 1999). The 
C-terminal tail is often unmodelled in apoenzyme structures, but adopts a folded 
conformation for L-cysteine bound structures, which is visible for CysE proteins 
from E. coli, H. influenzae, Y. pestis and Glycine max (soybean) (Pye et al., 2004) 
(Olsen et al., 2004) (Kim et al., 2006; Yi et al., 2013). We can observe this in Figure 
1.8, where the folded C-terminal tails are present in the cysteine bound structure 
(Figure 1.8c), but are undefined for L-serine and CoA-bound structures (Figure 1.8a 
and b). In this folded conformation the C-terminal tail competes directly with the 
binding site of acetyl CoA/CoA. This structural evidence supports the competitive 
inhibition mechanism for L-cysteine relative to acetyl CoA seen in inhibition assays 
(Hindson & Shaw, 2003);(Hindson, 2003; Johnson et al., 2004), making L-cysteine 
a competitive inhibitor for both L-serine and acetyl CoA.  
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Figure 1.8: Comparison of L-serine, CoA and L-cysteine CysE binding sites. (a) Structure of 
L-serine bound to CysE from soybean Glycine max (4N6B). L-serine represented as pink sticks. 
Phosphate represented as spheres (b) Structure of CysE with CoA bound from soybean Glycine max 
(4N69). CoA represented as orange sticks (c) Structure of CysE with L-cysteine bound from E. coli 
(1T3D). L-cysteine represented as purple sticks. Images generated using PyMOL. 
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Members of the left handed parallel β-helix (LβH) family, including CysE, have a 
conserved histidine in the active site (Johnson et al., 2005). The proposed 
mechanism for the acetyl-transfer reaction of CysE, is by a general acid-base 
catalysis, where the histidine, alongside a conserved aspartate act to form a catalytic 
triad with substrate L-serine. (Pye et al., 2004; Johnson et al., 2005). In E. coli this 
aspartate residue (Asp143) is positioned, in close proximity (2.8 Å) to the well 
conserved histidine (His158), which is predicted to transform the histidine into a 
strong base (Figure 1.9, Figure 1.10) (Pye et al., 2004). His158 activates the 
β-hydroxyl group of L-serine, for nucleophilic attack on the acetyl thioester of 
acetyl CoA, through acting as a base and accepting a hydrogen from the hydroxyl 
group (Figure 1.10). The nucleophilic attack on acetyl CoA forms a ternary 
complex between the enzyme, L-serine and acetyl CoA (E:L-serine:acetylCoA), 
before the histidine behaves as a general acid and donates a hydrogen to the sulphur 
group of acetyl CoA, leading to collapse of the complex and product release (Figure 
1.10) (Pye et al., 2004; Johnson et al., 2005). The CysE active site from E. coli with 
L-cysteine bound, has been used here to illustrate the co-ordination of the active 
site residues. Ternary intermediate modelling by (Pye et al., 2004), demonstrated 
that the carboxylic acid and amine group of L-serine would interact with the same 
active site residues as L-cysteine, allowing prediction of the reaction mechanism of 
CysE. The importance of these active site residues for catalysis has been 
demonstrated using site directed mutagenesis (Guan et al., 2008). The results from 
solvent deuterium isotope effect studies, would suggest that the generation of the 
E:L-serine:acetylCoA is the rate-limiting step of this reaction (Quinn & Sutton, 
2011). 
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Figure 1.9: Active site residues from CysE from E. coli with L-cysteine (1T3D). Hydrophilic 
interactions denoted as dashed yellow lines. Distances are in angstroms. Active site residues are 
denoted as sticks, coloured based on which chain they reside on, with chain A coloured cyan and 
chain B coloured orange. L-cysteine is denoted as purple sticks. Figure generated in PyMOL 
 
Figure 1.10: Reaction mechanism for CysE from E.coli. Substrates L-serine and acetyl CoA, are 
highlighted in red and blue, respectively. Reaction products O-acetylserine and co-enzyme A ae 
highlighted in green. Figure adapted from (Pye et al., 2004). 
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1.7.2 CysE kinetic mechanism 
The kinetics of CysE homologues from both bacteria and plants have been studied 
extensively. As CysE utilises two substrates for product formation there are two 
possible catalytic mechanisms: sequential and ping-pong. In a ping-pong 
mechanism, one of the products is released before all substrates have bound, 
generating an enzyme intermediate in the process. In a sequential kinetic 
mechanism, both substrates bind to the enzyme, before product(s) are released. This 
mechanism can be random, where both forms of substrate binding and product 
release occur or ordered where both substrates bind, and product(s) are released in 
a specific order. Both mechanisms generate a ternary complex 
(enzyme:substrateA:substrateB) (Fersht, 2017). Initial research hypothesised a 
ping-pong reaction mechanism for CysE (Leu & Cook, 1994). However, a 
combination of equilibrium isotope exchange experiments (Hindson & Shaw, 2003) 
and collection of Lineweaver-Burk plots (Hindson & Shaw, 2003; Johnson et al., 
2004; Benoni et al., 2017b) overwhelmingly supports a sequential binding 
mechanism and formation of the ternary complex in Figure 1.10. The exact type of 
sequential mechanism reported for CysE does vary, with a random sequential 
mechanism reported for CysE from E. coli (Hindson & Shaw, 2003) and an ordered 
binding mechanism reported for CysE from H. influenzae (Johnson et al., 2004), 
where acetyl CoA binds first, followed by L-serine (Figure 1.11). 
 
Figure 1.11: Ordered sequential mechanism for CysE from Haemophilus influenzae. The scheme 
here depicts that acetyl CoA is the first substrate to bind (A) and L-serine the second substrate to 
bind (B) and the product co-enzyme A is the first to leave (P) followed by product O-acetylserine 
(Q). A = acetyl CoA, B = L-serine, EAB = enzyme and substrates complex, EPQ = enzyme and 
products complex, P = co-enzyme A, Q = O-acetylserine. Figure from (Johnson et al., 2004).  
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1.8 CysE as a drug target  
Targeting the cysteine biosynthesis pathway has garnered interest regarding 
developing new antimicrobials, as cysteine biosynthesis pathways has been shown 
to be important for pathogen virulence and antibiotic resistance. As mammals 
synthesise L-cysteine through the reverse-transsulphuration of methionine obtained 
from diet, they do not have possess this reductive sulphate assimilation pathway, 
making this a promising target for drug development (Thomas & Surdin-Kerjan, 
1997; Hicks & Mullholland, 2018). Research into developing inhibitors has already 
begun for targeting CysK isoforms for pathogenic bacteria including 
S. typhimurium (Spyrakis et al., 2013) and M. tuberculosis (Brunner et al., 2016) 
A transcriptomic study showed that cysE (NGO_1423) is an essential gene in N. 
gonorrhoeae MS11 (Remmele et al., 2014). The authors used genome wide 
transposon-mediated mutagenesis to knockout and determine the essentiality of 
genes. Essentiality was tested by growing gene-deletion strains on GCB plates 
supplemented with L-cysteine. The essentiality of cysE demonstrates that for N. 
gonorrhoeae, L-cysteine requirements cannot be met solely from the import of 
cysteine from the environment. 
CysE has been evaluated as a drug target in E. coli. Inhibitors were identified 
through computational screening, and the most promising inhibitor was confirmed 
through inhibitor assays as a moderate inhibitor with an inhibition constant (Ki) of 
72 µM (Turnbull & Surette, 2010). Together, this information supports our project 
aims to biochemically characterise CysE, and in turn use this information for future 
computational-inhibitor screening and inhibitor design. 
The regulation of cysteine biosynthesis has not been well studied in N. gonorrhoeae. 
N. gonorrhoeae lacks the necessary transporters for glutathione uptake, and it is 
hypothesised that cysteine biosynthesis is responsible for the synthesis of 
glutathione (Seib et al., 2006). Although, N. gonorrhoeae has cysteine and cystine 
transporters, it is likely that to maintain high intracellular concentrations of 
glutathione and given the essentiality of both cysB and cysE, N. gonorrhoeae likely 
relies on de novo cysteine synthesis to meet these high L-cysteine demands.  
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Although N. gonorrhoeae cannot grow on sulphate as it lacks the ability to reduce 
sulphate to sulphide (by virtue of genome deletions and in frame stop codons) it is 
able to grow on thiosulphate as the sole source of sulphur. We suggest that 
N. gonorrhoeae has a different, yet functional cysteine biosynthetic pathway, and 
as an essential part of that, a functional serine acetyltransferase for step one in the 
synthesis of cysteine. Genome searches and sequence comparisons identified an 
annotated and likely functional serine acetyltransferase in N. gonorrhoeae FA1090.  
1.9 Research Objectives 
The aim of this research is to characterise a key enzyme in the N. gonorrhoeae 
cysteine biosynthetic pathway, CysE (EC 2.3.1.30). Characterisation of the 
biochemical and biophysical properties of CysE from N. gonorrhoeae guide future 
research for the development of new antimicrobials and will improve our 
understanding of the pathogenicity of N. gonorrhoeae. The following objectives 
were set to achieve this: 
Objective 1: 
Investigate the serine acetyltransferase activity and L-cysteine inhibition of CysE 
from N. gonorrhoeae. This will involve development of a kinetic assay to measure 
SAT activity and subsequent characterisation of Michaelis Menten kinetics, 
reaction mechanism and L-cysteine inhibition.  
Objective 2: 
Determine the three dimensional structure of CysE using protein crystallisation and 
X-ray diffraction. We will collect an apoenzyme structure, as well as structures 
complexed with either substrate (acetyl CoA and L-serine), and with product feed-
back inhibitor L-cysteine.  
Objective 3: 
Characterise the cysteine synthase complex from N. gonorrhoeae. This will involve 
purification of CysK alongside CysE, forming the CSC and biophysically 
characterising the stoichiometry of the complex and biochemical activity of CysE 
as a part of the complex. 
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2 Chapter 2  
Biochemical characterisation of CysE  
2.1 Introduction 
CysE is a key enzyme in the biosynthesis of cysteine in bacteria and plants. It 
catalyses the first step of the two-step cysteine synthesis reaction (Figure 1.2). CysE 
is a serine acetyltransferase (SAT, EC:2.3.1.30) and is a member of the left-handed 
β-helix (LβH) acyltransferase family. SATs catalyse the acyl transfer from acetyl 
CoA to the β-hydroxyl group of L-serine forming, O-acetylserine and co-enzyme 
A (Figure 1.5) (Pye et al., 2004; Johnson et al., 2005). In the second step of the 
cysteine synthesis reaction the activated form of L-serine, O-acetylserine, 
undergoes a condensation reaction with sulphide, catalysed by O-acetylserine 
sulfhydrylase (OASS, CysK, EC:2.5.1.47)(Kredich et al., 1969). CysE itself is 
regulated by feedback inhibition by the pathway product, L-cysteine (Hindson, 
2003; Johnson et al., 2004; Kumar et al., 2014; Benoni et al., 2017b). Sequence 
alignment of CysE homologues with CysE from N. gonorrhoeae, shows 
conservation of key secondary structures and the active site residues, His162 and 
Asp147 (His158 and Asp143 in E. coli), which form the catalytic triad with 
substrate L-serine, enabling acyl transfer (Figure 1.7 and Figure 1.10). Given that 
these active site residues are present, we predict that CysE from N. gonorrhoeae 
will have serine acetyltransferase activity. 
SATs and related LβH acyltransferases are a relatively well studied family of 
enzymes. CysE enzymes from other bacteria have an ordered sequential mechanism, 
with acetyl CoA binding ahead of L-serine (Johnson et al., 2004; Benoni et al., 
2017b). Initially CysE from E. coli was shown to have a random-order sequential 
mechanism (Hindson, 2003; Hindson & Shaw, 2003),  but more recent research by 
Benoni et al. (2017b) and Johnson et al. (2004), measuring CysE activity using a 
direct assay (monitoring absorbance at 232 nm), suggests an ordered mechanism in 
keeping with the majority of characterised CysE homologues. 
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The cysteine biosynthetic pathway is feedback inhibited by L-cysteine binding to 
CysE. L-cysteine competes directly with L-serine for the active site of the enzyme 
displaying competitive inhibition (Johnson et al., 2004). This mechanism of 
inhibition appears to be well conserved across the CysE family (Hindson, 2003; 
Johnson et al., 2004). Analysis of co-crystallised crystal structures of CysE with L-
cysteine, shows L-cysteine bound in the L-serine binding pocket located in the 
CysE active site (Pye et al., 2004; Kim et al., 2006), supporting the observation of 
L-cysteine being a competitive inhibitor relative to L-serine (Kredich & Tomkins, 
1966; Johnson et al., 2004). Interestingly, L-cysteine has also being reported to be 
a competitive inhibitor relative to acetyl CoA (Johnson et al., 2004). This is due to 
L-cysteine inducing a conformational change in the C-terminal tail, which 
precludes acetyl CoA from binding to the acetyl CoA binding site (Yi et al., 2013). 
This is thought to be part of the mechanism to prevent the unwanted acetylation of 
L-cysteine, given that it is isostructural to L-serine. 
We propose that CysE is a good target for the design of new antimicrobials to treat 
antimicrobial-resistant N. gonorrhoeae. Inhibitor design relies on not only 
structural characterisation of the enzyme, but also a detailed understanding of the 
enzyme’s kinetics and reaction mechanism. This chapter biochemically 
characterises CysE to understand the Michaelis Menten kinetics, mechanism of 
action and the mechanism of inhibition by L-cysteine. There are two published 
assays to measure CysE activity. The first is a coupled continuous assay where 
5,5-Dithiobis(2-nitrobenzoic acid) (DTNB) is used to measure CoA production at 
412 nm (Kredich & Tomkins, 1966). The second is a direct continuous assay where 
the depletion of acetyl CoA is measured at 232 nm over the course of the assay. The 
direct continuous assay as in (Chronis & Krishnan, 2004) was used for the kinetic 
characterisation of CysE in this chapter. Although activity is measured at a low 
wavelength, this simple assay gives a direct readout of CysE activity, whereas a 
coupled assay has the potential to induce error with the reaction of CoA with DTNB 
been a limiting factor in the reaction.  
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2.2 Materials and Methods 
2.2.1 Cloning of CysE for expression in Escherichia coli 
The cysE gene NGO_1423 was codon optimised for E. coli and ordered from 
Geneart (Thermo Fisher) (Appendix A). The synthetic cysE construct was cloned 
into expression vector pET28b with an N-terminal hexahistidine-tag, between Ndel 
and Xhol restriction sites by Dr Joanna Hicks (The University of Waikato). The 
NGO_1423 pET28b plasmid was checked by DNA sequencing before 
transformation into E. coli BL21 (DE3) for protein expression. Positive 
transformants were selected for by growing overnight at 37°C, Luria-Bertani (LB)-
agar (Appendix A2) supplemented with 50 µg.ml-1 kanamycin. 
2.2.2 Long-term storage of BL21 CysE expression strains 
Seeder cultures were prepared from positive transformants, by inoculating a single 
colony from a transformation plate into 10 ml of LB broth supplemented with 50 
µg.ml-1 kanamycin and incubated at 37°C, shaking at 200 rpm, overnight. 
Glycerol stocks were prepared from seeder cultures, 0.5 ml of seeder culture and 
0.5 ml of sterile 50% glycerol (w/v) were combined and stored at -80°C. 
2.2.3 CysE expression cultures 
Large scale expression cultures were prepared by inoculating 10 ml of seeder 
culture (prepared as per section 2.2.2) into 1 L of LB broth, supplemented with 50 
µg.ml-1 kanamycin. Cultures were incubated at 37 °C, 200 rpm until the culture 
reached log phase of growth (optical density at A600 = 0.5-0.7), at which point  
protein expression was induced by the addition of 1 ml of 0.75 M isopropylthio-β-
D-galactosidase (IPTG) (final concentration 0.75 mM). Cultures were returned to 
37°C, 200 rpm and incubated overnight. 
Expression cultures were centrifuged at 4,600g for 20 min at 4°C, after which the 
supernatant was discarded. The remaining cell pellet was resuspended in 25 ml of 
lysis buffer (50 mM Tris pH 8.0, 200 mM NaCl, 20 mM imidazole). The 
resuspended culture was transferred to a 50 ml falcon tube and centrifuged for a 
further 20 min at 4,600g, 4°C. After centrifugation, the supernatant was discarded, 
and the pellet was stored at -80°C. 
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2.2.4 Purification of CysE 
CysE was isolated and purified using immobilised metal affinity chromatography 
(IMAC) and gel filtration chromatography. Protein solubility was assessed using 
SDS-PAGE gel electrophoresis. Oligomeric state was measured using gel filtration 
chromatography and native-PAGE gel electrophoresis. 
2.2.4.1 Immobilised metal affinity chromatography 
Frozen CysE cell pellets (section 2.2.3) were thawed at room temperature. Cell 
pellets were resuspended by vortexing in 25 ml of lysis buffer (50 mM Tris pH 8.0, 
200 mM NaCl, 20 mM imidazole), and one cOmpleteTM, Mini, EDTA-free Protease 
Inhibitor Cocktail tablet (Roche, Switzerland) was added to inhibit cellular 
proteases. Cells were lysed using a Misonix sonicator on setting four (microtip 
probe (5-50 ml volume)). Cells were sonicated on ice for 5 min, in alternating 30 s 
bursts, with 30 s intervals of no sonication, (2.5 min of sonication in total). 
The sonicated lysate was centrifuged at 20,000g for 20 min at room temperature. 
The supernatant was filtered through 1.2, 0.45 and 0.2 µm filters. IMAC 
purification was carried out using either an AKTÄ Purifier fast protein liquid 
chromatography (FPLC) system (GE Life Sciences, New Zealand) or an NGC 
FPLC system (BioRad). The same method for IMAC and gel filtration was used for 
either FPLC system. The filtered supernatant was manually loaded onto a 
HisTrapTM HP 5 ml column (GE Life Sciences, New Zealand) that was pre-
equilibrated in lysis buffer. The column was attached to the FPLC and flushed with 
20 ml of lysis buffer at 2 ml.min-1. The concentration of elution buffer (50 mM Tris 
pH 8.0, 200 mM NaCl, 1 M imidazole) was gradually increased to 50%, over 25 
ml, to elute the HexaHis-tagged CysE.   
2.2.4.2 Gel filtration chromatography 
At room temperature (22°C), IMAC peak fractions were concentrated in a 10,000 
Da MWCO Amicon® spin concentrator at 3,600g for 20 min, or until the volume of 
protein concentrate was reduced to 0.75 ml. The concentrate was loaded onto a 
Enrich 650 analytical gel filtration column (Bio-Rad Laboratories, USA), pre-
equilibrated in gel filtration buffer (50 mM Tris pH 8.0, 100 mM NaCl) with a flow 
rate of 1 ml.min-1. Concentrated protein was manually loaded into the injection loop 
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of the FPLC for injection onto the column. After sample injection 28 ml of gel 
filtration buffer was run at 1 ml.min-1 through the column. Fractions of eluted 
protein were collected and stored at room temperature. 
2.2.4.3 SDS and native-PAGE gel electrophoresis 
Native-PAGE gels were used for both native-PAGE and SDS-PAGE gel 
electrophoresis. This was accomplished by addition of SDS to sample loading 
buffer and running buffer. Native-PAGE gels were composed of both a resolving 
and stacking layer, at 12 and 5% polyacrylamide, respectively. All gels were made 
in house in a multi-gel caster (Hoefer). The resolving layer was prepared by mixing 
the “Resolving layer” components listed in Table 2.1, and filling the gel caster, 
leaving a three cm gap at top of the gel plate. Isopropanol was then applied to the 
top of the gel (3 ml) and was left until the resolving layer had polymerised (30 min). 
Once set, the isopropanol layer was carefully removed, the stacking layer was 
prepared by combining “Stacking Layer” components listed in Table 2.1 and filling 
to the top edge of the gel caster. A ten well comb was inserted into the top of each 
gel, before leaving to set at room temperature for 30 min. Gels were stored at 4°C 
for up to four weeks. 
Protein samples were prepared for gel-loading by mixing 15 µl of sample with 5 µl 
of 4x SDS loading dye (also known as Quench, Q4) (Appendix B). 20 µl of sample 
was loaded per well, along with 10 µl of Precision Plus ProteinTM ladder (Bio-Rad 
Laboratories, USA) per gel. The gels were run in 1 x Tris-Glycine SDS-PAGE 
running buffer (Appendix B) at a constant 150 V, until the loading dye migrated to 
the end of the resolving gel, where it was reduced to 100 V. The gel was run until 
the dye migrated to the end of the gel.  
Protein bands were visualised by staining in Coomassie Fairbanks stain (Appendix 
B). Gels and stain were heating by microwaving for 30 s, followed by five min 
incubation at room temperature with agitation (120 rpm). Stained gels were rinsed 
with distilled water and left in destaining solution (10% acetic acid) overnight. 
Destained gel bands were visualised using an Omega Lum™ gel imager (Aplegen, 
USA). 
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Table 2.1: Components for five native-PAGE gels. Ammonium persulphate (APS) stock solution 
was prepared fresh weekly. 
Component 
12% Resolving 
layer (ml) 
8% Stacking layer 
(ml) 
Resolving buffer (1.5 
M Tris pH 8.8) 
7.5 - 
Stacking buffer (1 M 
Tris pH 6.8) 
- 1.6 
30% 
Polyacrylamide/Bis 
(375:1) (v/v) 
10.0 2.125 
10% APS (w/v) 0.15 0.063 
10% TEMED 0.015 0.0063 
MQH20 10.35 8.625 
 
2.2.4.4 Measuring the oligomeric state of CysE 
Previously, the Enrich650 gel filtration column (Bio-Rad Laboratories, USA) was 
calibrated in gel filtration buffer (50 mM Tris pH 8.0, 200 mM NaCl) using Gel 
Filtration Standards (Bio-Rad Laboratories, USA), by Dr Joanna Hicks. The 
calibration curve can be found in Appendix B.2. The molecular weight of CysE was 
calculated taking the peak elution volume (Ve) and calculate the Kav gel phase 
distribution co-efficient using Equation 2.1, where Vo is the column void volume 
and Vc is the total column volume: The calibration standard curve relating Kav and 
molecular weight was used to determine the molecular weight of CysE from the 
calculated Kav. 
Equation 2.1: Formula for calculating gel phase distribution co-efficient 
𝐾𝑎𝑣 =
𝑉𝑒 − 𝑉𝑜
𝑉𝑐 − 𝑉𝑜
 
2.2.4.5 Measuring protein concentration NanodropTM 
Protein concentration was determined by NanodropTM 2000 (Thermofisher, USA) 
measuring absorbance at 280 nm. This protein quantification method works by 
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measuring the absorbance of tryptophan residues (280 nm). Protein concentration 
was calculated using Beer-Lambert law (Equation 2.2), where absorbance readings 
were corrected by dividing the NanodropTM reading (1 Abs = 1 mg.ml-1) by the 
molar absorption co-efficient of the CysE protein, (Ɛ = 0.555 L mol-1/cm-1) as 
determined by ProtParam (Gasteiger et al., 2005). 
Equation 2.2: Beer-Lambert equation. A= absorbance, Ɛ = molar absorption co-efficient (L mol-
1/cm-1), l = pathlength (cm) and c = concentration (molL-). 
𝐴 = 𝜀𝑐𝑙 
2.2.4.6 Disulphide bond prediction 
Disulphide prediction for CysE was carried out using DiANNA 1.1 (Ferrè & Clote, 
2006). 
2.2.5 Kinetic assay parameters 
CysE was purified by IMAC and gel filtration chromatography as per sections 
2.2.4.1 and 2.2.4.2. Protein concentration was measured by absorbance at 280 nm 
using a NanodropTM (section 2.2.4.5). All CysE protein used in assays was purified 
the same day. All assays were carried out in gel filtration buffer (50 mM Tris pH 
8.0, 100 mM NaCl). Master stocks for both substrates L-serine and acetyl CoA, 
were prepared in gel filtration buffer (50 mM Tris pH 8.0, 100 mM NaCl). An 
enzyme working stock of 0.134 mg.ml-1 (5.3 nM, CysE monomer 31.6 kDa) was 
prepared at the beginning of the assay and stored at room temperature (22°C) before 
and for the duration of the assays.  
2.2.5.1 Assay parameters 
Assay data was collected using the same gel filtration buffer (50 mM Tris pH 8.0, 
100 mM NaCl). Assays were carried out in a 500 µl quartz cuvette, with total 
assay volume of 400 µl. Assay components  
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Table 2.2: CysE kinetic assay setup. Concentrations of substrate were varied by adjusting the 
volume of substrate master stock added, unless the volume to be added was less than 4 µl or greater 
than 40 µl, and then a more dilute or concentrated stock was used, respectively. This was done to 
prevent lowering the overall temperature of the assay, as substrate stocks were stored on ice for the 
duration of the assays. Amount of enzyme used for each reaction was kept constant (0.00156 mg.ml-
1). 
Component Volume (µl) 
Buffer 315-387 
L-serine 4-40 
Acetyl CoA 4-40 
Enzyme 5 
Total 400 
 
All substrate stocks were prepared in assay gel filtration buffer (50 mM Tris pH 8.0, 
100 mM NaCl). Acetyl CoA stock aliquots were stored following manufacturer’s 
instructions at -80°C, to prevent unwanted hydrolysis of acetyl CoA to co-enzyme 
A. Stocks were thawed at room temperature and stored short-term on ice for assays. 
Acetyl CoA was purchased as a powdered tri-lithium salt from Roche (MW = 827.5 
g.mol-1) and stored as a powder at 4°C. L-serine stocks were also prepared and 
stored at -80°C. 
Serine acetyltransferase activity of CysE was monitored via depletion of substrate 
acetyl CoA at 232 nm (ΔƐ232 = 4500 M-1 cm-1, absorbance of thioester bond) using 
an adapted method from (Chronis & Krishnan, 2004). Absorbance at 232 nm was 
recorded at 0.125 s intervals for 30 s using a ThermoSpectronic Heλios 
spectrophotometer (ThermoScientific, USA). Initial velocity data (Δ 
Absorbance/second) was derived from linear regression analysis of the first ten 
seconds of the reaction (unless otherwise stated). The catalytic rate 
(ΔAbsorbance/second) of CysE can be calculated directly from the depletion of 
acetyl CoA by dividing the rate by -1, as one mol of acetyl CoA is used to make 
one mol of O-acetylserine. All datapoints were collected in duplicate, unless 
otherwise stated. All assays were conducted at room temperature (22°C).  
 
 
Chapter 2 
 
32 
2.2.5.2 Michaelis Menten analysis 
The Michaelis constant (KM) is the concentration of substrate required for an 
enzyme to produce half its maximum theoretical rate (Vmax) (Fersht, 2017). KM is a 
measure of the affinity of the enzyme for the substrate of interest. Hence, when an 
enzyme has a low KM for a substrate, the enzyme has a high affinity for the substrate 
and will require lower concentrations of substrate before the enzyme’s binding sites 
become saturated. If an enzyme has a high KM for a substrate, this indicates that the 
substrate has a low affinity for the substrate and higher concentrations will be 
needed for saturation (Fersht, 2017). Approximate values of Vmax can be achieved 
under saturating concentrations of substrate. This is a theoretical value that can be 
never reached in a practical setting but is denoted as being the rate where the 
concentration of substrate is2 x KM (Vmax = 2 x KM). 
The KM and Vmax were calculated for each substrate by varying the concentration of 
the substrate of interest, while keeping the other at saturating concentrations, so that 
it is not rate limiting. Saturating conditions are defined as concentrations 2 x KM, 
and greater L-serine Michaelis Menten curves were collected over a range of L-
serine concentrations (0.1-200 mM). Acetyl CoA Michaelis Menten plots were 
collected over a range of acetyl CoA concentrations (0.1-1 mM). Both Michaelis 
Menten plots were collected at fixed saturating conditions of the other substrate.   
KM and Vmax were determined by non-linear regression fit of the Michaelis Menten 
equation (Equation 2.3) using GraphPad Prism (version 8.2.0, Windows, GraphPad 
Software, La Jolla California USA,). 
Equation 2.3: The Michaelis Menten equation. S = substrate, KM = Michaelis constant, v = rate, 
vmax = theoretical maximum rate. 
𝑣 =
𝑣𝑚𝑎𝑥[𝑆]
𝐾𝑀 + [𝑆]
 
Enzyme catalytic efficiency was measured by calculating the catalytic constant (kcat ) 
and the specificity constant kcat/KM. Kcat is a measure of the amount of product being 
formed over time, per unit of enzyme (s-1). This is calculated by dividing the Vmax 
rate (M.s-1), by the molar concentration of hexameric enzyme. The catalytic 
efficiency kcat/KM (M
-1s-1) was calculated by dividing the kcat (s
-1) by the KM (M). 
Catalytic efficiency values were calculated for each substrate. 
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2.2.5.3 CysE inhibition assays 
L-cysteine inhibition assays were measured using a modified assay method from 
section 2.2.5.1. Modifications included the addition of L-cysteine (final 
concentration, 0.01-40 µM) to the assay mixture before initiating the reaction by 
the addition of enzyme.  
Cysteine stocks (0.1 and 1.0 mM) were made up fresh in gel filtration buffer (50 
mM Tris pH 8.0, 100 mM NaCl) and stored on ice throughout preparation and 
assays to prevent unwanted oxidation of L-cysteine to L-cystine. 
2.2.5.4 Substrate inhibition 
Substrate inhibition was measured through non-linear regression fit of the substrate 
inhibition Equation 2.4 using GraphPad Prism (version 8.2.0, Windows, GraphPad 
Software, La Jolla California USA,). 
Equation 2.4: Substrate inhibition equation. S = substrate, Ki = inhibition constant, KM = Michaelis 
constant, v = rate, vmax = theoretical maximum rate. 
𝑣 =
𝑣𝑚𝑎𝑥  [𝑆]
𝐾𝑀[𝑆](
1 + [𝑆]
𝐾𝑖
)
 
2.2.5.5 Measuring cysteine inhibition parameters 
The concentration of inhibitor that reduces enzyme rate by half (IC50) were 
calculated by fitting the “log [inhibitor] vs. normalised response” (Equation 2.5) to 
rate data (mM.s-1) using GraphPad Prism (version 8.2.0, Windows, GraphPad 
Software, La Jolla California USA,). GraphPad calculated IC50 from plotting rate 
against logarithms of increasing concentrations of L-cysteine  
Equation 2.5: Equation for determining IC50 of L-cysteine. I = inhibitor concentration, v = rate, v0 
= rate with no inhibitor present, v/vo = normalised rate. 
𝑣
𝑣𝑜
=
100
(1 + 10([I]−log 𝐼𝐶50))
 
For characterising the inhibition type of L-cysteine, it was decided due to time 
constraints to investigate the inhibition mechanism of only one substrate during this 
thesis. We decided to investigate the Ki and type of inhibition L-cysteine displayed 
relative to L-serine, as L-cysteine has been shown to bind directly to the active site 
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of our enzyme, and so we believe would be a good model for guiding novel inhibitor 
design. 
Before characterising the type of inhibition exhibited by L-cysteine on L-serine, the 
Ki was estimated by, plotting the reciprocal rate against increasing concentrations 
of inhibitor, to create a Dixon plot (Equation 2.6) (Dixon, 1953). The rate was 
calculated by monitoring rate over increasing concentrations of L-cysteine, at fixed 
concentrations of L-serine and saturating concentrations of acetyl CoA (0.45 mM). 
Rate data was collected at L-serine concentrations of 1,3 and 10 mM. When plotted 
the data forms a straight line. Linear regression analysis was fitted for each L-serine 
concentration and the intercept of these points were plotted. The Ki can be derived 
from the x-coordinate of the intersection of these lines.  
Equation 2.6: Dixon plot equation. Ki = inhibition constant, S= substrate, v = rate, Vmax = theoretical 
maximum rate, I = inhibitor. 
1
𝑣
=
𝐾𝑀 + [𝑆]
𝑉max [𝑆]
+ [𝐼]
(
𝐾𝑀
𝐾𝑖
+
[𝑆]
𝐾𝑖
)
𝑉𝑚𝑎𝑥[𝑆]
 
To determine the inhibition type of L-cysteine, Michaelis Menten plots were 
collected and fitted using Equation 2.7. Rates were collected with varying 
concentrations of L-serine (1, 3 and 10 mM) and at fixed concentrations of L-
cysteine (0.5x, 1x, 2x and 4x Ki) of L-cysteine, at saturating conditions of acetyl 
CoA and varying the concentrations of L-serine.  
Equation 2.7: Competitive inhibition model. KM = Michaelis constant, KMobs =observed KM when 
inhibitor is present, S = substrate, v = rate, vmax = theoretical maximum rate, Ki = in inhibition 
constant, I = inhibitor. 
𝑣 =
𝑣𝑚𝑎𝑥[𝑆]
𝐾𝑀𝑜𝑏𝑠 + [𝑆]
 
Where  
𝐾𝑀𝑜𝑏𝑠 = 𝐾𝑀(
1 + [𝐼]
𝐾𝑖
) 
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2.3 Results and Discussion 
2.3.1 Expression and purification of CysE 
To successfully characterise CysE from N. gonorrhoeae we need to purify soluble 
and active protein. Prior to the start of this MSc research, Dr Joanna Hicks had 
cloned CysE and optimised protein expression and purification (Section 2.2.1 and 
2.2.3). During assay development we encountered enzyme stability issues, but we 
were able to optimise our purification and assay method to mitigate this. 
CysE was successfully purified by IMAC and gel filtration chromatography. The 
IMAC purification chromatogram in Figure 2.1a show that CysE elutes at ≈ 45% 
elution buffer (450 mM of imidazole). The corresponding SDS-PAGE gel of the 
IMAC fractions, demonstrates that the majority of E. coli protein present in the 
supernatant is removed during IMAC purification (Figure 2.1b). This results in 
relatively pure CysE protein of approx. 32 kDa (Figure 2.1b, blue arrow) consistent 
with the predicted molecular weight of the CysE monomer (31.6 kDa, calculated  
as per section 2.2.4.5). Fractions containing IMAC purified CysE (Figure 2.1, green 
bar) were concentrated for gel filtration purification (Figure 2.1a) as per section 
2.2.4.2. 
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Figure 2.1: IMAC purification of CysE at room temperature. (a) IMAC chromatogram of A280 nm 
shows volume (left X-axis) and concentration of elution buffer (%B right X-axis). Data from 0-40 
ml has being excluded for scaling purposes. (b) 12% SDS-PAGE gel of CysE IMAC purification. 
CysE protein is labelled with a blue arrow and is present in all samples (the insoluble pellet (P), 
soluble supernatant (S) and IMAC fractions (green bar)). Molecular weights of Precision Plus 
Protein Standards (L) in kDa are labelled. Purification was carried out at room temperature. 
IMAC-purified CysE underwent a final purification step via gel filtration 
chromatography (section 2.2.4.2). CysE eluted as a single peak from an ENrich 650 
analytical gel filtration column with an elution volume of 12.56 ml (Figure 2.2a, 
orange bar). Using the ENrich 650 calibration curve (Appendix B.1.2), the apparent 
molecular weight from the elution volume is 193.8 kDa. The predicted molecular 
weight of the CysE monomer is 31.6 kDa, which suggests that CysE elutes as a 
hexamer (6 x 31.6 kDa = 189.6 kDa). No protein was present in the void volume of 
the column (10.56 ml) indicating that CysE did not aggregate and remained soluble 
during purification. The corresponding SDS-PAGE of the gel filtration column 
show pure CysE protein of approximately 32 kDa (Figure 2.2b). 
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Figure 2.2: Gel filtration purification of CysE. (a) Enrich 650 gel filtration chromatogram shows 
the elution of a large peak at 12.56 ml (b) 12% SDS-PAGE analysis shows high yield and purity of 
CysE (orange bar). CysE protein band is labelled with a blue arrow. Molecular weights of Precision 
Plus Protein Standards (L) in kDa are labelled. Purification was carried out at room temperature. 
 
2.3.2 Assay optimisation 
We developed an assay to measure the activity of CysE from N. gonorrhoeae, based 
on the method for characterising CysE activity from soybean (Chronis & Krishnan, 
2004). All assays were carried out in gel filtration/ assay buffer (50 mM Tris pH 
8.0, 100 mM NaCl) at 22°C. Assays were set up as per section 2.2.5.1. All raw data 
used is listed in Appendix B.3.  
Initially trial assays were collected to determine the appropriate amount of enzyme 
to collect initial velocity data for Michaelis Menten kinetics. Enzyme concentration 
was optimised to have sufficient linear initial velocity to measure during the assay 
(10 s). Assays were set up using concentrations of 0.1 mM and 1 mM acetyl CoA, 
and L-serine, respectively, based on saturating substrate concentrations for soybean 
CysE, reported by (Chronis & Krishnan, 2004). The following concentrations of 
CysE were trialled: 0.00156, 0.0031 or 0.0625 mg.ml-1. Rates were monitored for 
5 min (Figure 2.3a) but initial velocity was examined from the first 30 s of the assay 
(Figure 2.3b). The enzyme concentration, 0.0625 mg.ml-1, was deemed to be too 
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high as the reaction reaches completion within the ten seconds, making it 
impossible to measure the initial velocity (Figure 2.3a). This prompted trialling 1:20 
and 1:40 dilutions, 0.031 and 0.0156 mg.ml-1 respectively. Rate curvature within 
the first ten seconds is present for 0.0031 mg.ml-1, but further dilution to 0.00156 
mg.ml-1 eliminated this. The initial velocity (ΔAbs/s) calculated from the first ten 
seconds of each concentration was plotted (Figure 2.4). Here both lower 
concentrations show that initial velocity is dependent on enzyme concentration and 
increases linearly with increasing enzyme concentration. Hence, it was decided that 
a final CysE concentration of 0.00156 mg.ml-1 would be used for the collection of 
Michaelis Menten kinetics. 
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Figure 2.3: Dependence of rate on CysE concentration. Monitoring CysE activity at 232 nm with 
varying concentrations of enzyme. (a) CysE activity monitored by depletion of absorbance at 232 
nm for 5 min. (b) First 30 s from plot (a), was used to visualise the linear region. Final enzyme 
concentrations trialled 0.00156, 0.0031 and 0.0625 mg.ml-1. All assays were initiated with 5 µl of 
enzyme. Absorbance plotted represent single replicates. Raw untransformed data used to create plot 
(a) in Appendix B.3. 
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Figure 2.4: Rate dependence on concentration of CysE. Rates were calculated from the first ten 
seconds of the reaction. Rates are plotted for 0.00156, 0.0031 and 0.06250 mg.ml-1. Single replicates 
were collected. Linear regression fitted for enzyme concentrations 0.00156 and 0.0031 mg.ml-1. 
Non-linear regression curve fitted for all enzyme concentrations. 
Initial activity assays were collected by varying the concentration of L-serine and 
acetyl CoA. Initial assay data (data not shown) demonstrated that CysE activity 
increased linearly at concentrations greater than 0.1 mM acetyl CoA and 1 mM L-
serine, indicating that saturating substrate concentrations taken from(Chronis & 
Krishnan, 2004) are not saturating for CysE from N. gonorrhoeae. These results 
prompted us to collect initial velocity data at higher concentrations of each substrate 
to determine approximate saturating concentrations to use for collection of 
Michaelis Menten curves. 
We collected preliminary data varying concentrations of the substrates L-serine and 
acetyl CoA, but over the course of several hours, we observed a slow steady 
decrease in enzyme activity (Figure 2.5). Further investigation demonstrated that 
this drop in activity only occurred when the CysE enzyme stock was stored on ice 
and did not occur when a sample of that enzyme stock was stored at room 
temperature (Figure 2.5).  
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Figure 2.5: Effect of cold inactivation on CysE activity. Rates were measured at constant 
concentrations of acetyl CoA (0.45 mM) and L-serine (10 mM). CysE enzyme stock was stored on 
ice (circles) for the duration of the assay, and temperature control enzyme was stored at room 
temperature (triangles). All assays were carried out at room temperature (22°C). Single replicates 
are plotted. 
Upon interrogation of the literature, it has been reported that CysE homologues lose 
activity when exposed to low temperatures (0-4°C), a phenomenon known as cold 
inactivation (Mino et al., 2001; Yi et al., 2013). Cold inactivation occurs in 
multimeric enzymes and is where hydrophobic interactions between these subunits 
weaken at cold temperatures, leading to dissociation into smaller oligomeric units 
(Privalov, 1990). Cold inactivation experiments with CysE homologues report the 
dissociation of the CysE hexamer into trimers and monomers (Mino et al., 2001). 
This is in keeping with the CysE trimer-dimer interface and the intra-trimer 
interface, where the majority of interactions are hydrophobic (Pye et al., 2004; Yi 
et al., 2013; Kumar et al., 2014). This process is reversible, as activity can be 
restored by incubating at room temperature, and has been linked to the reformation 
of hexameric CysE (Mino et al., 2001). With this information we further optimised 
our purification and assay to reduce the effect of cold inactivation on CysE activity. 
To prevent cold inactivation of CysE, we removed all cold storage steps from the 
purification process, which included protein concentration at 4 °C, storage at 4 °C 
between IMAC and gel filtration chromatography and storing enzyme stocks at 
room temperature. Before we realised that CysE was susceptible to cold 
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inactivation, we had collected a preliminary Michaelis Menten curve for both acetyl 
CoA (0.1-1.0 mM) and L-serine (as per section 2.2.5.1). This initial data showed 
rate inhibition at concentrations of acetyl CoA greater than 0.55 mM and was 
attributed to substrate inhibition (Figure 2.6). Both Michaelis Menten (Figure 2.6a) 
and substrate inhibition (Figure 2.6b) models were fitted using GraphPad Prism 
(section 2.2.5.2 and 2.2.5.4). Given that only single replicates were collected for 
determining the acetyl CoA curve, the curve was used to inform the saturating 
concentrations for collection of the Michaelis Menten curve for L-serine, which was 
chosen to be 0.45 mM as it was the highest concentration before substrate inhibition 
became apparent. 
 
Figure 2.6: Preliminary acetyl CoA Michaelis Menten curve for cold inactivated CysE. (a) 
Nonlinear regression fit of Michaelis Menten (line). (b) Same as data (a) but nonlinear regression fit 
of substrate inhibition (line). L-serine was kept at a constant concentration of 1 mM L-serine. CysE 
was stored on ice for the duration of this assay. 
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A Michaelis Menten curve was collected for L-serine with cold inactivated CysE 
(CysE purified with cold exposure steps and stored on ice for duration of the assay). 
To compare the effect of low temperature on CysE activity we recollected this 
Michaelis Menten curve with CysE purified and stored at room temperature (Figure 
2.7). Both curves were collected at room temperature (i.e. assay buffer at room 
temperature), saturating concentrations of acetyl CoA (0.45 mM) and using 0.00156 
mg.ml-1of CysE. Initial velocities were collected for increasing concentrations of 
L-serine (0.1 to 12 mM) (Figure 2.7). The Michaelis Menten model was fitted 
(section 2.2.5.2) to each data set. The KM and Vmax for cold treated CysE was 0.7728 
± 0.2397 mM and 0.002896 ± 0.0002476 mM.s-1 respectively. Room temperature 
CysE had a KM of 0.5784 ± 0.2803 mM and a Vmax of 0.003980 ± 
0.0005616  mM.s- 1. Visual inspection of the plots suggests that the Vmax of the 
room temperature CysE is likely greater than reported, as the rate is still increasing 
linearly with increasing concentrations of L-serine.  
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Figure 2.7: Effect of temperature on CysE Michaelis Menten kinetics. (a) Datapoints plotted with 
connecting lines. (b) Data from (a) with the Michaelis Menten equation (Equation 2.3) fit (line). All 
assays were conducted at 22°C. Room temperature dataset is depicted as circles and cold 
temperature dataset is depicted as squares. Plots were collected at a saturating concentrations of 
acetyl CoA (0.45 mM) and 0.00156 mg.ml-1 of CysE. Each datapoint is the mean calculated from 
duplicates, and plotted error bars are SEM. 
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For CysE stored on ice the KM for L-serine increased, indicating a lower affinity for 
the substrate and Vmax decreased, indicating a reduced rate. To explain this 
difference in activity due to temperature, we investigated whether CysE was 
dissociating from a hexamer into a lower oligomeric state when exposed to cold 
temperatures. We analysed samples of cold treated (refrigerated on ice (0°C) 
overnight) and room temperature CysE by native-PAGE gel electrophoresis as per 
section 2.2.4.3.  
Using native-PAGE electrophoresis we were able to visualise the presence of two 
extra bands for cold treated CysE (0°C), compared to CysE that was stored at room 
temperature (22°C). Given that the lowest running band is present for both 
temperature conditions, this is band is likely the hexameric form of CysE. Given 
that there are two extra bands present for cold-treated CysE samples, these most 
likely lower oligomeric states of CysE, consistent with either a trimer, dimer or 
monomer. 
 
Figure 2.8: Native-PAGE analysis of cold inactivated CysE. Two concentrations of CysE were 
incubated overnight at room temperature or at 0°C. Hexamer band as indicated by blue arrow, 
suspected trimer/dimer/monomer are labelled with an orange and green arrow. (L) The ladder could 
not be visualised and so has not being labelled. 
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To confirm these results from Figure 2.8, the cold inactivated mixture was prepared 
again (incubation at 0°C overnight) and analysed by gel filtration chromatography 
(as per 2.2.4.2). Interestingly, we were only able to visualise a single peak with an 
elution volume of 12.56 ml (data not shown) that resembled the same elution profile 
as seen in Figure 2.2a. The cold inactivation seen for CysE homologues has been 
shown to be reversible and has been attributed to the reassociation of dissociated 
trimers to form a hexamer (Mino et al., 2001). As our gel filtration purification was 
conducted at room temperature, with room temperature buffer, we assume the 
hexamer reformed. Storing CysE at 4°C long term and preincubating at room 
temperature to restore activity was considered, but it was decided this would 
introduce a potential source of variability, so these assays were optimised removing 
exposure of CysE to low temperatures.  
Interestingly, we still observed saw the effects of low temperature of CysE in our 
assays that were carried out at room temperature (assay buffer was kept at room 
temperature). Although the effects of cold inactivation are reversible, Mino et al. 
(2001) observed that hexamer formation and restoration of enzyme activity 
occurred after minutes of incubation at room temperature. As assays were initiated 
with enzyme, there would have been insufficient time for reactivation of CysE and 
explains the effects of cold inactivation seen during our assays. This would also 
explain why only a CysE hexamer was seen during gel filtration purification of cold 
inactivated CysE, as the column takes minutes to run, giving the CysE hexamer 
time to reform.  
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2.3.3 CysE stability  
After minimising cold exposure, it was observed that enzyme activity dropped after 
overnight incubation at room temperature. This prompted us to trial the addition of 
buffer additives to see if we could stabilise enzyme activity.  
Loss of activity at room temperature has been observed for diluted CysE 
(1.3  µg.ml-1) from H. influenzae, which is comparable to the concentrations of 
CysE used for our assays (0.125 mg.ml-1) (Johnson et al., 2004). The authors from 
this study trialled additives and found that the addition of bovine serum albumin 
(BSA) (100 µg.ml-1) improved enzyme stability. We trialled the addition of BSA 
(100 µg.ml-1) to purified and diluted CysE (results not shown) (as per section 
2.2.4.2), but results were inconclusive. 
The addition of reducing agents at low concentrations is known for promoting 
stability of enzymes, by preventing the unwanted oxidation of cysteine residues 
(Wingfield, 2001). Using disulphide prediction program DiANNA, CysE was 
shown to have two cysteines (Cys84 and Cys99) per monomer with a low 
disulphide prediction score of 0.01681 (where 1 being most likely to form a 
disulphide bond) (Ferrè & Clote, 2006). To prevent unwanted oxidation of these 
residues the addition of reducing agents were trialled. Dithiothreitol (DTT) (1 mM) 
and 2-betamercaptoethanol (1 mM) were added to enzyme stocks directly after 
purification (prepared as per section 2.2.4.2), but results were inconclusive. Given 
the amount of time spent on assay optimisation for cold-inactivation it was decided 
to purify and perform all Michaelis Menten and L-cysteine inhibition assays on the 
same day to prevent loss of CysE activity affecting results. 
2.3.4  Michaelis Menten kinetics of CysE 
Michaelis Menten curves were collected for both substrates, L-serine and acetyl 
CoA. The purpose of collecting this data is to determine KM and Vmax for CysE. 
These kinetic parameters provide insight into the enzyme’s affinity for its substrates 
and can be used to calculate measures of catalytic efficiency including, kcat and 
kcat/KM. These kinetic parameters are also needed for collection of inhibition assays. 
The Michaelis Menten plot for acetyl CoA was created by plotting initial velocities 
(mM.s-1) against increasing concentrations of acetyl CoA (0.01-1.0 mM) at 
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saturating concentrations of L-serine (10 mM). The resulting Michaelis Menten plot 
(Figure 2.9), does not show the classical rate curvature at high concentrations of 
acetyl CoA (rate plateau at high substrate concentrations), but instead inhibition is 
present (from 0.55 mM acetyl CoA), suggesting some form of inhibition. Initially, 
we fitted a substrate inhibition model (Equation 2.4) using GraphPad (Figure 2.9a). 
Substrate inhibition is where substrate binds to the enzyme to form an unproductive 
enzyme:product:substrate complex (Fersht, 2017). The model fits the rates plotted 
relatively well (R2 = 0.9145), but there is some slight deviation from the model at 
higher concentrations of acetyl CoA, (0.8 -1.0 mM). The KM and Vmax values 
calculated by the substrate inhibition model are 500 mM and 0.01 mM.s-1, 
respectively. Given that these incredibly large values exceeded the concentration 
range plotted, we deemed this not scientifically relevant and other models were 
fitted. 
To determine the KM and Vmax for acetyl CoA, we fitted the Michaelis Menten 
model (Equation 2.3) calculating the KM and Vmax for acetyl CoA to be 0.152 ± 0.05 
mM and 5.93 x10-3 ± 5.74 x 10-4 mM.s-1, respectively (Figure 2.9b).  
Further comparison of the goodness of fit of the substrate inhibition and Michaelis 
Menten models, demonstrates that the substrate inhibition model fits the rates better 
than the Michaelis Menten plot, with R2 values of 0.9145 and. 0.8375, respectively. 
So, while the kinetic parameters generated from the substrate inhibition model are 
not suitable for use, we do believe that substrate inhibition is the cause of inhibition 
present in our acetyl CoA Michaelis Menten plot. 
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Figure 2.9: Enzyme rate dependent on increasing concentrations of acetyl CoA. (a) Fit of substrate 
inhibition model (Equation .). (b) Same data as (a) fit with Michaelis Menten equation (Equation ). 
Rates measured at saturating concentrations of L-serine (10 mM). Circles represent mean derived 
from duplicates and error bars are SEM. Plot was collected at room temperature (22°C). 
The substrate inhibition observed for the acetyl CoA Michaelis Menten curve with 
10 mM L-serine, is comparable to the acetyl CoA Michaelis Menten curve with 
1 mM L-serine (Figure 2.10). The rates appear to be within error, up until substrate 
inhibition becomes at 0.55 mM acetyl CoA, where the rates deviate. For the 1 mM 
L-serine plot, the rates are lower at higher concentrations of acetyl CoA, compared 
to the 10 mM L-serine plot. It is unclear whether this difference in substrate 
inhibition seen in these two datasets is due to differences in L-serine concentration 
or temperature treatment of CysE, as both are variables in these datasets. To 
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determine which factor is responsible, we would recollect the 1 mM L-serine 
dataset using CysE enzyme purified and stored at room temperature. 
  
Figure 2.10: Comparison of Michaelis Menten data collected at different concentrations of L-serine. 
Lines plotted are connecting lines between each data point. All data collected with the same CysE 
concentration (0.00156 mg.ml-1). Plots were collected either at 10 mM L-serine (circles) or 1 mM 
L-serine (squares). CysE was stored on ice for collection of 1 mM L-serine data. 1 mM L-serine 
dataset taken from Figure 2.6 and 10 mM L-serine dataset taken from Figure 2.9. 
For the collection of Michaelis Menten plots for a dual substrate enzyme, the 
concentration of one substrate is varied, while the other substrate is kept at 
saturating conditions to prevent from becoming rate limiting (Fersht, 2017). Often 
concentrations greater than 2 x KM are used, but given that substrate inhibition is 
present, 0.45 mM acetyl CoA was chosen to be the saturating concentration for 
collection of the L-serine Michaelis Menten plot, as it is the highest concentration 
of acetyl CoA before the rate becomes affected by substrate inhibition. 
The L-serine Michaelis Menten curve was generated by plotting initial velocities 
(mM.s-1) against increasing concentrations of L-serine (0.1-200 mM) (section 
2.2.5.2). We observed classical Michaelis Menten behaviour for L-serine, with 
substrate saturation of the enzyme seen at 20 mM of L-serine (Figure 2.11). The 
KM for L-serine was 2.58 ± 0.73 mM and the Vmax 6.63 x 10
-3 ± 4.72 x 10- 4 mM.s-
1. The difference in KM values for each substrate (2.58 mM L-serine vs. 0.152 mM 
acetyl CoA, (Table 2.3), demonstrates that CysE has a greater affinity for acetyl 
CoA compared to L-serine. KM values for both L-serine and acetyl CoA are 
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comparable to those that have been collected for other CysE bacterial homologues, 
given that these were collected under different experimental conditions (Table 2.4).  
 
Figure 2.11: L-serine Michaelis Menten-fitted curve. Acetyl CoA kept at saturating concentration 
(0.45 mM). Circles represent mean derived from duplicates for each datapoint and error bars SEM. 
Data collected at room temperature (22°C). 
The Vmax values for both substrates are comparable, with 6.63 x 10
-3 and 
5.93  x10- 3  mM.s- 1, for L-serine and acetyl CoA, respectively (Table 2.3). The 
catalytic turnover (kcat) values were derived from the Vmax as per section 2.2.5.2. 
The kcat for CysE is 822 ± 59 and 730 ± 70 s
-1, for L-serine and acetyl CoA, 
respectively, treating CysE as a hexamer. The kcat calculation assumed a hexamer 
of CysE monomers as it is not clear if all active sites are active at the same time, 
and also for comparison to literature values. The kcat values are within magnitude 
of values reported for CysE homologues (Table 2.3). 
Table 2.3: Summary of Michaelis Menten kinetic parameters for substrates L-serine and acetyl CoA. 
Values are means calculated from duplicates and are quoted with SEM. kcat values are reported for  
Parameter L-serine Acetyl CoA 
KM (mM) 2.58 ± 0.73 0.152 ± 0.05 
Vmax (mM.s-1) 6.63 x 10-3 ± 4.72 x 10- 4 5.93 x 10-3 ± 5.74 x 10-4 
kcat (s-1) 822 ± 59 730 ± 70 
kcat/KM (L-serine)(M-1.s-1) 3.19*105 4.80*106 
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The specificity constant, kcat/KM, values were calculated by dividing the kcat by the 
KM for each substrate The kcat/KM values for CysE are 3.19 x 10
5 and 4.80 x 106   M-
1s-1 for L-serine and acetyl CoA, respectively. kcat/KM values of 10
5/106 indicate that 
the enzyme is not diffusion limited (kcat/KM ≥ 108 M-1s-1) (Schurr & Schmitz, 1976). 
These values are comparable with values calculated for other CysE bacterial 
homologues (Table 2.3).  
Table 2.4: Comparison of CysE kinetic parameters. DTNB = DTNB-coupled assay, A232 = monitor 
depletion of acetyl CoA at 232 nm, Nr  = not reported. kcat values are reported for the CysE hexamer. 
Organism 
KM 
(Ser/AcCoA) 
kcat 
(Ser/AcCoA) (s-
1) 
kcat/KM 
(Ser/AcCoA) (M-
1s-1) 
pH, Temperature, 
Assay method 
Reference 
N. 
gonorrhoeae 
FA1090 
2.58/0.152 822/730 3.19*105/4.80*106 8.0, 22°C, A232 nm  This thesis 
E. coli 1.3/0.3 228/306 1.34*105/2.12*105  7.0, 20°C, A232 nm 
(Benoni et 
al., 2017b) 
S. typhimurium 3.2/0.4 135/nr 3.4*105/nr 7.0, 25°C, DTNB 
(Leu & 
Cook, 
1994) 
H. influenzae 4.7/0.7 2200/nr 4.70x105/nr 7.5, 25°C, DTNB 
(Johnson et 
al., 2004) 
 
Interestingly there is a 10 fold kcat/KM increase for acetyl CoA compared to L-serine. 
This can be attributed to CysE having a greater affinity for acetyl CoA, with a ten 
fold lower KM for acetyl CoA (0.152 mM) compared to L-serine (2.58 mM). KM 
values tend to reflect concentrations of substrate observed in the intracellular 
environment. Currently there are no reported values for L-serine or acetyl CoA 
concentrations for Neisseria species. In E. coli the intracellular concentrations of 
acetyl CoA have been reported to vary between 20 – 600 µM as it is dependent on 
growth phase and nutrient availability (Takamura & Nomura, 1988). The KM of 
acetyl CoA being in the middle of that range at 152 µM, would mean that CysE 
would be saturated with acetyl CoA. For L-serine, intracellular concentrations in E. 
coli have been reported to be 68 µM (Sajed et al., 2015). The acetyl CoA values fits 
with the observation that KM values tend to be around intracellular concentration of 
the substrate ((Bennett et al., 2009)), whereas this is not the case for L-serine as the 
low intracellular concentration to KM ratio for L-serine is much lower (68µM vs. 
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2.58 mM, concentration vs. KM L-serine). This ratio would suggest that CysE would 
not be saturated with L-serine, and assuming intracellular concentrations are similar 
in N. gonorrhoeae this undersaturation would limit activity of CysE in vivo (Davidi 
et al., 2016).   
Michaelis Menten kinetics of CysE enzymes from other E. coli and H. influenzae 
consistently display classical (where at high concentrations of substrate the 
enzymatic rate plateaus at ≈ Vmax) plots for acetyl CoA, but observe substrate 
inhibition for L serine Michaelis Menten plots (Kredich & Tomkins, 1966; Johnson 
et al., 2004; Benoni et al., 2017b). Interestingly we observe the opposite where 
substrate inhibition is present for Michaelis Menten plots for acetyl CoA and not L-
serine. Substrate inhibition occurs when a substrate binds to the enzyme to form an 
unproductive complex. Based on the reaction mechanism for CysE homologues, we 
predict that CysE most likely has a sequential mechanism, which is in keeping with 
the proposed formation of the ternary complex during acyl transfer to L-serine 
(Johnson et al., 2004; Benoni et al., 2017b). CysE from H. influenzae has been 
demonstrated to have an ordered mechanism where acetyl CoA binds and is 
released first (Johnson et al., 2004). Assuming a sequential mechanism, it is 
possible at high concentrations of acetyl CoA for CoA to be released from the 
enzyme:O-acetylserine (enzyme:product) complex, only for acetyl CoA bind to the 
acetyl CoA/CoA binding site forming an unproductive complex, explaining the 
substrate inhibition we observe for acetyl CoA.  
Previously researchers have investigated the design of inhibitors for a CysE related 
hexapeptide acetyltransferase, GlmU (Olsen et al., 2007). Inhibitors for GlmU 
targeted the acetyl CoA binding site, instead of the active site (L-serine binding 
site). For CysE, targeting the acetyl CoA binding site, might prove to be a good 
target when screening for inhibitors.  
Once we had determined the KM for each substrate, before commencing with the 
collection of inhibitor assays, we re-confirmed that our rate was still dependent on 
enzyme concentration at our new saturating concentrations of 10 and 0.45 mM for 
L-serine and acetyl CoA, respectively (Figure 2.12). The initial velocity was 
derived from the first ten seconds of the assay. Here, initial velocity increases 
linearly with enzyme concentration, up until concentrations greater than 0.00156 
Chapter 2 
 
54 
mg.ml-1. This demonstrates that initial velocity is still dependent on enzyme 
concentration, and so inhibitor assays were collected using 0.00156 mg.ml-1 of 
CysE. 
  
Figure 2.12: Dependence of rate on the concentration of CysE. All data was collected at saturating 
concentrations of L-serine and acetyl CoA, 10 and 0.45 mM, respectively. Circles represent mean 
derived from duplicates for each datapoint and error bars are SEM. 
2.3.5 Characterising L-cysteine inhibition of CysE 
For CysE proteins, feedback inhibition by L-cysteine is well documented across 
both bacterial and plant species. Here, we characterised L-cysteine inhibition 
relative to substrate, L-serine, for CysE. To characterise this inhibition, we carried 
out inhibitor assays to generate IC50, Dixon and Michaelis Menten plots, for the 
calculation of IC50 , Ki and mode-of-inhibition for L-cysteine respectively. 
2.3.5.1 L-cysteine IC50 assays 
Inhibition assays were set up as per section 2.2.5.3. Initial velocity data was 
collected over a range of L-cysteine concentrations (0.8-40 µM). Substrates were 
held at saturating conditions for acetyl CoA (0.45 mM, 3 x KM) and non-saturating 
conditions of L-serine (1 mM, 0.5x KM). Enzyme concentration was kept constant 
at 0.00156 mg.ml-1for all assays. CysE activity is inhibited by increasing 
concentrations of L-cysteine (Figure 2.13a). To calculate the IC50 for L-cysteine, 
the normalised rate was plotted against the log of L-cysteine concentration and 
fitted to Equation 2.5 using GraphPad (Section 2.2.5.5) (Figure 2.13b). The 
calculated IC50 for L-cysteine is 5.01 ± 0.403 µM. 
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Figure 2.13: IC50 plot for L-cysteine. (a) Normalised rate plotted against increasing concentrations 
of L-cysteine. (b) Normalised rate plotted against log10 of L-cysteine concentrations. Line represents 
the fit of Equation 2.5. Substrate concentrations were kept constant, at 0.45 mM and 1 mM, for 
acetyl CoA and L-serine, respectively. The IC50 for L-cysteine is 5.01 µM. CysE activity (Rate, 
mM.s-1) was normalised by dividing the rate by rate of the no-inhibitor control. Data points are mean 
and error bars are SEM derived from two replicates.  
To determine the Ki of L-cysteine, the reciprocal rate was plotted against increasing 
concentrations of L-cysteine (0-80 µM), at fixed concentrations of L-serine (1, 3 
and 10 mM, 0.3x, 1x and 4x KM), to generate a Dixon plot (Dixon, 1953). 
Concentrations of acetyl CoA were kept at saturating concentrations (0.45 mM). It 
is possible to determine mode-of-inhibition for an inhibitor by analysing the 
intersection of the linear regressions for each substrate concentration (Dixon, 1953). 
For competitive inhibition or mixed inhibition, these linear regressions would be 
expected to intersect behind the y-axis and above the x-axis. For non-competitive 
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inhibition, these linear regressions would intersect behind the y-axis but on the x-
axis. Finally, for uncompetitive inhibition we would expect to find a series of 
non-intersecting linear regressions running parallel to each other. Linear regression 
analysis was fitted for each L-serine concentration dataset. For L-cysteine (Figure 
2.14), we see that the intersection of the linear regressions occurs above the y-axis 
and behind the x-axis, suggesting either competitive or mixed mode inhibition. 
Based on Equation 2.6, the x co-ordinate of the intercept is -Ki. Here the coordinates 
are -4.095, 58.3, so the calculated Ki of L-cysteine is 4.095 ± 1.081 µM. 
 
Figure 2.14: Dixon plot showing competitive inhibition. Rates plotted for 1 mM L-serine (circles), 
3 mM L-serine (squares) and 10 mM L-serine (triangles). Acetyl CoA was kept at constant saturating 
conditions of 0.45 mM. Data points represent mean of two replicates and error bars SEM. Lines 
represent fit of linear regressions. 
The calculated Ki for L-cysteine was used to generate Michaelis Menten plots to 
determine the type of inhibition displayed by L-cysteine relative to L-serine (Figure 
2.15). Rates were plotted against increasing concentrations of L-serine at fixed 
concentrations of L-cysteine. To determine mode-of-inhibition, datasets were fitted 
using non-competitive, uncompetitive, mixed and competitive inhibition models 
offered in GraphPad. The competitive model had the best degree of fit, with a 
R2  =  0.9183 compared to 0.7325, 0.8325, 0.9183, for uncompetitive, non-
competitive and mixed inhibition models, respectively. A mixed mode-of-
inhibition was ruled out even though it had good degree of fit (R2 = 0.9183) as the 
fit was ambiguous. A Ki of 4.64 ± 1.11 µM was calculated for L-cysteine by fitting 
the competitive inhibition model. It should be noted that due to time constraints, the 
datasets used for Dixon plot analysis were also used for Michaelis Menten 
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inhibition analysis. Hence why there are only a few data points per L-cysteine 
concentration. In the future these plots will be recollected based on the 
concentrations used to generate the L-serine Michaelis Menten plot (Figure 2.11), 
at fixed concentrations of L-cysteine based on the Ki  (4.01 µM) calculated from the 
Dixon plot  (0.5-4 x Ki = 2-18 µM)  
For competitive inhibition, the inhibitor is competing directly with L-serine for the 
active site, and therefore it would be expected that at high concentrations of L-serine, 
inhibitory effects of L-cysteine would be overcome, and that the Vmax should 
approximately be the same value for all L-cysteine datasets. It would be expected 
that the KM would increase with increasing concentrations of L-cysteine. The 
inhibition plot (Figure 2.15) does not show this trend, instead the Vmax values for 
all data sets are dissimilar and decrease as inhibitor concentration increases. We 
acknowledge that independent of the graph pad R2 values, the data below resembles 
a more non-competitive mode of inhibition i.e. the Vmax decreases with increasing 
concentrations of inhibitor. The rates have not plateaued for any of the datasets 
plotted, and so it is impossible to say with any certainty what the Vmax values are. 
Given the results from the Dixon and Michaelis Menten plots and that a competitive 
inhibition model for L-cysteine relative to L-serine, is well documented for CysE 
homologues (Hindson, 2003; Johnson et al., 2004; Benoni et al., 2017b), and is 
supported by crystallographic CysE structures with cysteine bound in the active site 
(Pye et al., 2004; Yi et al., 2013), we believe that CysE does have a competitive 
inhibition mechanism relative to L-cysteine.  
To confirm this more data needs to be collected including repeating these Michaelis 
Menten plots and including higher concentrations of L-serine (20, 100 and 200 mM). 
If a competitive inhibition mechanism is present, the rate inhibition would be 
overcome at high concentrations of L-serine (Vmax of inhibitor Michaelis Menten 
plots ≈ Vmax of uninhibited plots). 
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Figure 2.15: Fit of competitive inhibition model for L-cysteine relative to L-serine. Rates were 
measured over a range of concentrations of L-serine (0-10 µM) at collected at fixed concentrations 
of L-cysteine (20, 30, 40 and 60 µM), and saturating concentrations of acetyl CoA (0.45 mM). Data 
points represent the mean derived from two replicates and error bars represent SEM. Lines represent 
fit of competitive inhibition model Equation 2.7. 
2.3.5.2 Analysis of IC50 and Ki values for L-cysteine 
The IC50 value is a measure of the amount of inhibitor required to reduce enzyme 
activity by half (Fersht, 2017). The calculated IC50 for L-cysteine was shown to be 
5.01 µM. This value is notably greater than the reported IC50 values for bacterial 
CysE homologues Table 2.5. It is noted, that there is some variability between IC50 
values reported (Table 2.5) and this is likely due to differences in  enzyme 
concentration and concentration of substrates (for competitive inhibitors), which 
are shown to influence the IC50 (Fersht, 2017). A better value for comparison of 
inhibitor potency is Ki , as it is not influenced by as many factors as IC50 values, 
therefore making them better for comparison to other Ki  values. 
The Ki for L-cysteine was calculated using different two methods, the Dixon plot 
(4.1 ± 1.081 µM) and Michaelis Menten inhibition plot (4.643 ± 1.11 µM), 
producing values that are in good agreeance within each other (Table 2.5). We 
compared the Ki value calculated from the Dixon plot to literature values, as 
although the preferred method is to derive the Ki from the Michaelis Menten 
inhibition plot, the datasets used for this analysis were incomplete (as discussed 
previously).  
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CysE from N. gonorrhoeae has a Ki of 4.1 µM, which is ten-fold greater than the 
lowest reported value of 0.4 µM from S. typhimurium. The highest Ki reported in 
Table 2.5 is 10 µM for H. influenzae (Johnson et al., 2004). This variation can be 
partially attributed to differences in assay conditions, most notably pH. pH has been 
shown to influence both L-serine and L-cysteine binding in CysE homologues. For 
example, CysE from H. influenzae (activity measured at pH 6.5) reports a relatively 
high KM for L-serine (17 mM) and Ki for L-cysteine (10 µM)(Johnson et al., 2004), 
whereas values collected at a pH 7.6 in S. typhimurium have a KM  of 3.2 mM and 
Ki of 0.4 µM (Kredich & Tomkins, 1966).Given that the pH optima for CysE 
homologues is approximately 7.6 (Qiu et al., 2013), and our assays were collected 
at pH 8.0, the effect of pH on our reported Ki values is likely minimal and the 
increased Ki values are due to a genuine reduction in CysE sensitivity to L-cysteine 
inhibition. 
Currently there is no data available for intracellular concentrations of L-cysteine in 
N. gonorrhoeae. Interestingly, the Ki values for L-cysteine for CysE enzymes 
(Table 2.5), are much lower than reported intracellular concentrations of L-cysteine 
(204 ± 45 µM) found in E. coli (Sajed et al., 2015). It is unclear what the nutrient 
availability of L-cysteine is in the urogenital tract, but given the high intracellular 
concentrations of glutathione (Seib et al., 2006) and host-derived oxidative stress, 
it is possible that these high L-cysteine demands are met by reducing inhibition 
sensitivity L-cysteine, allowing for continued L-cysteine synthesis at higher 
L-cysteine concentrations compared to other CysE homologues.  
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Table 2.5: Comparison of CysE homologue IC50 and Ki parameters for L-cysteine. The Ki for S. 
typhimurium is not reported in reference. Nr =not reported All values are mean ± SEM. Ki value for 
CysE from N. gonorrhoeae is calculated from Dixon plot Figure 2.14. 
Organism Ki (µM)  IC50 (µM) 
Condition: 
pH, Temp, 
Assay method 
Reference 
N. gonorrhoeae 
4.095 ± 
1.081 
5.01 ± 
0.403 
8.0, 22°C, A232 nm This thesis 
E. coli 1 
0.18 ± 
0.02* 
7.5, 25°C, DTNB 
*7.5, 20°C A232 nm 
(Mino et al., 
1999),*(Benoni et al., 
2017b) 
S. typhimurium 0.4 1.1 7.6, 25°C, DTNB 
(Kredich & Tomkins, 
1966) 
H. influenzae 10±5 Nr 6.5, 25°C, DTNB (Johnson et al., 2004) 
 
2.4 Conclusions and future directions 
In this chapter we present that CysE from N. gonorrhoeae is a functional serine 
acetyltransferase. CysE was shown to be susceptible to cold inactivation, most 
likely due to hexamer dissociation, in keeping with observations of other CysE 
homologues (Mino et al., 2001; Benoni et al., 2017b). CysE from N. gonorrhoeae 
differs from other CysE enzymes in that it does not experience substrate inhibition 
by L-serine (Kredich & Tomkins, 1966; Benoni et al., 2017b), but instead is subject 
to substrate inhibition by acetyl CoA. 
CysE from N. gonorrhoeae is sensitive to feedback inhibition by L-cysteine. 
Calculated IC50 and Ki values were shown to be higher than other characterised 
CysE proteins. L-cysteine displays a competitive mode-of-inhibition, relative to L-
serine. This is consistent with reported L-cysteine inhibition of other CysE enzymes 
(Johnson et al., 2004; Benoni et al., 2017b) and reported crystal structures of CysE 
proteins with L-cysteine bound in the active site (Figure 1.8) (Olsen et al., 2004; 
Pye et al., 2004). Combined, this evidence suggests that while CysE is subject to 
regulation by L-cysteine, it has reduced sensitivity, which would support the idea 
of N. gonorrhoeae having greater intracellular concentrations of L-cysteine, needed 
to meet high L-cysteine demand for mitigating oxidative stress encountered during 
host infection. 
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Future work includes investigation as to the type of inhibition cysteine exhibits on 
CysE relative to acetyl CoA. In other bacteria it was reported that CysE displays 
competitive inhibition to both substrates, despite binding in the L-serine binding 
pocket in the active site (Johnson et al., 2004; Pye et al., 2004). Preliminary 
inhibitor screening for the CysE-related hexapeptide acyltransferase, GlmU, 
identified potential inhibitors that target the acetyl CoA binding site (Olsen et al., 
2007). To characterise this inhibition, we will collect Dixon and Michaelis Menten 
based inhibitor plots.  
Based on our collected data we hypothesise a sequential mechanism for CysE from 
N. gonorrhoeae. Future work includes collecting kinetic data at varying substrate 
concentrations for analysis using a Lineweaver-Burke plot to determine reaction 
mechanism (Fersht, 2017). 
The kinetic data, reaction mechanism and mode of inhibition by L-cysteine 
presented in this chapter are vital pieces of information to understand the reaction 
mechanism of CysE. Understanding the reaction mechanism is crucial for 
computational inhibitor screening to identify lead compounds for CysE inhibition. 
For example, given that L-cysteine is an effective competitive inhibitor of CysE, 
the active site could be targeted by screening inhibitors that are isostructural to 
L-cysteine. Using methods developed in this thesis, the lead inhibitor compounds 
identified by computational screening will be tested in vitro to determine the IC50, 
Ki and mode-of-inhibition.  
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3 Chapter 3 
Structural and biophysical characterisation of 
CysE and the cysteine synthase complex 
3.1 Introduction 
CysE is a serine acetyltransferase (SAT, EC 2.3.1.30) that catalyses the first step of 
the two-step cysteine biosynthesis pathway. CysE catalyses the acetylation of L-
serine, producing O-acetylserine. L-cysteine is formed from O-acetylserine, by the 
addition of sulphide and removal of acetate, catalysed by CysK. CysE and CysK 
bind together to form the cysteine synthase complex (CSC). The CSC is unusual in 
that most protein complexes are formed to shuttle substrates/products from one 
enzyme to another. The CSC differs in that the C-terminal tail of CysE binds in the 
active site of CysK to inhibit its activity (Campanini et al., 2005; Huang et al., 2005; 
Kumaran et al., 2009). One hypothesis for formation of the CSC is for modulation 
of sulphur flux in bacterial metabolism (Hell et al., 2002; Wirtz et al., 2012). 
Alignment of the CysE protein sequence from N. gonorrhoeae with other bacterial 
homologues, demonstrates moderate sequence similarity compared to other 
proteobacterial species (average 55% sequence similarity), but shows strong 
conservation of hexapeptide repeat, active site and C-terminal tail residues (Figure 
1.7). Although structures of CysE from other bacteria have been characterised, there 
has been no investigation into the structure of CysE or formation of the cysteine 
synthase complex from N. gonorrhoeae. 
We propose CysE is a valid drug target for the design of new antimicrobial 
compounds to treat gonorrhoea. To do this we need a high-resolution structure for 
CysE (Reichau et al., 2011), with and without substrates bound. These structures 
can then be used for computational inhibitor screening to identify lead compounds 
for further development. As there is no structure for CysE from N. gonorrhoeae, 
one of the aims of this thesis is to purify, crystallise and determine the structure of 
CysE using X-ray crystallography.  
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3.2 Materials and Methods 
3.2.1 Crystallisation of CysE 
3.2.1.1 Protein preparation 
CysE protein was expressed and purified following methods in section 2.2.2 and 
section 2.2.4, respectively. Protein concentration was determined by NanodropTM 
as per section 2.2.4.5. 
3.2.1.2  High throughput crystallisation screens 
High throughput crystallisation screens were set up to identify promising 
crystallisation conditions that could be further optimised to produce crystals 
suitable for X-ray diffraction. The following screens: IndexTM-HR2-144, PEGRx 
HTTM-HR2-086, CrystalHTTM-HR2-130 and the SaltRxHTTM–HR2-136 (Hampton 
Research, U.S.A.), were used. Screens were set up in low profile 96-2 well 
INTELLI-PLATE and were set up using the Mosquito crystallisation robot (TTP 
LabTech Ltd., USA). Each crystallisation condition had a reservoir solution 
(crystallisation solution) of 200 µl and 200 nl sitting drops. Protein drops consisted 
of a 1:1 mixture of reservoir solution and concentrated protein. Screens were 
checked weekly for crystal formation using a dissection microscope. 
3.2.1.3 Hanging drop fine screens 
Promising crystallisation conditions from high throughput screens were further 
optimised through scaling up to hanging drop fine screens. 24 well VDX trays were 
set up with mother liquor (well reservoir) volumes of 500 µl or 1000 µl from 
concentrated stock solutions. Hanging drops were prepared by mixing a 1:1 ratio 
(1:1 µl or 2:2 µl) of mother liquor and concentrated protein solution on a siliconised 
cover slip, before inverting drop-side down, over a well, lined with silicone grease. 
For each condition, crystallisation parameters such as pH, drop size and the 
concentration of protein and precipitant were optimised. Crystallisation drops were 
checked for crystal growth under a dissection microscope, daily for one week and 
weekly thereafter. 
3.2.1.4 Ligand co-crystallisation 
High throughput screens were set up as per protocol (section 3.2.1.2), but with the 
addition of acetyl CoA or L-cysteine to the concentrated protein stocks (final 
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concentration of 0.1 mM and 5.5 mM, respectively). Promising conditions were 
further optimised through setting up fine drop screens as per section 3.2.1.3, with 
the exception of adding the ligand to the protein stock before setting up the 
crystallisation drops.  
3.2.1.5 Seeding method 
Crystal seeding was employed to increase crystal size and improve diffraction 
quality. This method was used only for hanging drop fine screens, which were set 
up as per section 3.2.1.3. Before sealing the well, a single cat whisker was dragged 
across a CysE crystal grown from a previous crystal screen and swiped through the 
fresh CysE protein drop. The well was sealed as per section 3.2.1.3. Crystallisation 
drops were checked for crystal growth under a dissection microscope, daily for one 
week and weekly thereafter. 
3.2.1.6 Final structure crystallisation condition 
Purified protein was concentrated to 24 mg.ml-1 and stored on ice for a short period 
of time, as prolonged incubation at room temperature lead to precipitation. This 
optimised tray was based on a condition identified from high throughput 
crystallisation tray HR2-144 IndexTM : 35% TacsimateTM (v/v) pH 7.0 (Hampton 
Research, USA). TacsimateTM is a mixture of seven organic acids and was used 
both as a precipitant and a buffer in CysE crystallisation (refer to Appendix C for 
TacsimateTM composition). Trays were set up as per section 3.2.1.3. The crystals 
used for X-ray diffraction were grown using whisker seeding. Drop composition 
was made up with 2:2 µl drops (mother liquor: protein concentrate). All crystals 
were grown at 18°C. 
3.2.1.7 Crystal preparation for X-ray diffraction 
Each crystal was transferred using a cryo-loop, to a cryo-protectant solution, 
consisting of a modified mother liquor solution with the addition of 15% glycerol 
(v/v) as a cryo-protectant. Crystals were then flash cooled in liquid nitrogen. 
Crystals were stored short-term in liquid nitrogen (one to two days) before data 
collection. 
3.2.1.8 Ligand soaking 
Ligand soaking was employed as an alternative method to obtaining the structure 
of CysE complexed with either substrates or inhibitors. This was carried out for 
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both L-serine and L-cysteine. Ligand soaks were prepared by the addition of either 
L-cysteine (5.5 mM) or L-serine (6 mM) to mother liquor solution. Crystals were 
grown and prepared for data collection as per section 3.2.1.7., with the addition of 
an extra soaking step, before transferring to the cryo-protectant solution. 
3.2.2 Data collection 
X-ray diffraction data was collected at the Australian Synchrotron (Melbourne, 
Victoria) on the MX2 beamline (McPhillips et al., 2002), equipped with an EIGER 
x 16M detector (Dectris, Switzerland).  
3.2.3 Data processing 
3.2.3.1 Indexing, integration and scaling 
The CysE dataset diffraction images were indexed, integrated and scaled, using 
XDS (Kabsch, 2010). Merging of reflections was carried out using AIMLESS 
(Evans & Murshudov, 2013) from the CCP4 suite (Winn et al., 2011). Data quality 
was assessed through AIMLESS (Evans & Murshudov, 2013) and through 
manually viewing diffraction images using ALBULA (Dectris, Switzerland). FreeR 
flag dataset (5% of dataset reflections not to be used in refinement and used to 
compute Rfree) was generated in AIMLESS. 
3.2.3.2 Detection of twinning and non-crystallographic symmetry 
Data was analysed for evidence of twinning and translational non-crystallographic 
symmetry (tNCS) in AIMLESS from the CCP4 suite (Winn et al., 2011) (Evans & 
Murshudov, 2013) and phenix.xtriage from PHENIX suite  
3.2.4 Structural analysis 
3.2.4.1 Matthew’s coefficient  
The total number of monomers in the asymmetric unit was determined by 
calculating the solvent content using the Matthew’s coefficient (Matthews, 1968) 
program, as a part of the CCP4 program suite (Winn et al., 2011). 
3.2.4.2 Molecular replacement 
The structure of CysE from Y. pestis (3GVD) was retrieved from the protein data 
bank (PDB). A single monomer was extracted from this file, in PyMOL (The 
PyMOL Molecular Graphics System, Version 2.3.2 Schrödinger, LLC). Molecular 
Chapter 3 
 
66 
replacement was carried out using phenix.phaser (McCoy et al., 2007), from the 
PHENIX suite (Adams et al., 2010). 
3.2.4.3 Model building and refinement 
The model was initially built and refined using the program phenix.autobuild 
(Terwilliger et al., 2008) from the PHENIX suite (Adams et al., 2010). The 
resulting structure, was further built manually using the program COOT (Emsley 
& Cowtan, 2004). For manual building and refinement in COOT, the 2Fo-Fc and 
Fo-Fc electron density maps, were set to 1σ and 3σ, respectively. After each round 
of structure manipulation, phenix.refine was used to run rounds of real-space 
refinement (Afonine et al., 2012).  
3.2.4.4 Ligand fitting and refinement 
We prepared the structure for ligand fitting by building and refining the protein 
structure and adding in waters using phenix.refine. We used the program 
phenix.ligandidentification to screen 200 common ligands. Phenix.ligandfit was 
used to search specifically for ligands of interest (Terwilliger et al., 2006) 
(Venkatachalam et al., 2003). Visual inspection and manual real space refinement 
were carried out in COOT. 
3.2.4.5 Structural analysis 
Assessment of Ramachandran outliers was carried out using MolProbity (Chen et 
al., 2010), from the PHENIX suite (Adams et al., 2010). Images of the model and 
maps were generated using programs PyMOL (The PyMOL Molecular Graphics 
System, Version 2.3.2 Schrödinger, LLC) and COOT (Emsley & Cowtan, 2004). 
Hydrogen bonds were classified as being moderate for distances between 2.5-3.2Å 
and weak for 3.3-4.0Å (Jeffrey, 1997).  Bond distances were measured in PyMOL 
and COOT. Comparing structures was conducted through calculating root mean 
square distances (r.m.s.d) using alignment tool in PyMOL. The surface area and 
buried residue calculations for the trimer/hexamer interfaces were carried out using 
PDBePISA (Krissinel & Henrick, 2007). ENDscript 3.0 was used to identify 
secondary structural features (Robert & Gouet, 2014), alongside visual inspection 
in PyMOL. LigPlot+ was used to visualise ligand-protein interactions (Laskowski 
& Swindells, 2011).  
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3.2.5 Formation of the cysteine synthase complex 
Protocol for forming the CSC was based on a method by (Benoni et al., 2017b). 
CysE and CysK were purified individually before being used for CSC formation. 
3.2.5.1 Purification of CysK 
CysK was purified using IMAC and gel filtration chromatography as per section 
2.2.4.1 and 2.2.4.2 by Dr Joanna Hicks with minor modifications. CysK was 
purified with the addition of CysK co-factor, pyridoxal 5’ phosphate (PLP). 250 µl 
of PLP (final concentration 0.3 mM) was added to cell pellets just before sonication 
(section 2.2.4). CysK without the addition of PLP was also purified and used to 
form the CSC. 
3.2.5.2 Formation of the cysteine synthase complex 
CysE and CysK were combined together (CysE:CysK, molar ratio of 1:1 or 3:2) 
and were incubated on ice for 15 min (final volume 0.5 ml). After incubation, 20 µl 
was kept aside for native-PAGE gel electrophoresis. Apparent molecular weights 
of CysE, CysK and the CSC, were measured using gel filtration chromatography. 
3.3 Results and Discussion 
3.3.1 Crystallisation of CysE 
Before the commencement of this master’s research, Dr Joanna Hicks grew 
diffracting CysE protein crystals and collected datasets from three crystals (2.15, 
2.56 and 2.6 Å respectively). All crystals were from the same crystallisation 
condition; 5% MPD, 10% PEG 6000, 0.1M HEPES (pH 8.0) (Figure 3.1). The data 
collected was processed in the H32 space group. However, despite many attempts 
we were unable to solve the structure, with R values not improving during 
refinement with the best final model having a Rwork/Rfree score of 0.29/0.39. Further 
interrogation of the datasets using phenix.xtriage showed that these datasets had a 
high percentage of twinning. Attempts to detwin the data using phenix.refine and 
DETWIN (CCP4 suite), were unsuccessful. It was decided to screen and optimise 
alternative crystallisation conditions to produce un-twinned high-quality crystals. 
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Figure 3.1: Initial crystallisation and diffraction of CysE. (a) Crystallisation condition; 5% MPD 
(v/v), 10% PEG6000 (v/v), 0.1M HEPES pH 8.0. (b) Example diffraction image of crystal. (c) Close 
up of diffraction pattern from (b). Diffraction images generated using ALBULA. 
High throughput crystallisation screens were trialled (section 3.2.1.2) and we 
observed several promising crystallisation conditions that produced micro-crystals. 
Multiple crystallisation conditions were scaled up to fine screen hanging drops, 
where crystallisation parameters such as pH and precipitant concentration were 
varied. The best formed crystals grew in 35% (v/v) TacsimateTM (pH 7.0) and so 
this condition was further optimised. While some well-formed crystals grew in this 
condition, the majority of the crystals were poorly formed (Figure 3.2). To improve 
crystal quality, pH, TacsimateTM concentration, and drop size were optimised. The 
shape of the crystal improved if the pH was lowered (7.0 to 6.5) and larger crystals 
were obtained by increasing the final drop volume from 2 to 4 µl. However, the 
diffraction quality of these crystals was poor (3.5 - 4.0 Å, data not shown). 
Therefore, seeding techniques were employed to improve crystal quality. 
 
Figure 3.2: CysE crystals grown in TacsimateTM. (a) Crystal from 35% TacsimateTM (v/v) pH 6.5. 
(b) Crystal from 21% TacsimateTM (v/v) pH 6.6. 
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Crystallisation drops were whisker seeded (using a crystal pre-grown in the same 
crystallisation condition) and set up with a 10-20% reduction in both protein and 
precipitant concentration to prevent spontaneous nucleation events from occurring 
and promote growth of larger crystals. Crystals grew faster using this method (≤1 
week vs. 2-4 weeks) and produced well-formed single crystals. The best formed 
crystals grew between 26-28% (v/v) TacsimateTM and between pH 6.5-6.8. 
Crystals were prepared for X-ray diffraction by immersing in a cryoprotectant 
solution consisting of the crystallisation solution plus 15% (v/v) glycerol, before 
flash freezing in liquid nitrogen. Diffraction data were collected at the Australian 
synchrotron on the MX2 beamline, equipped with an EIGER detector, as per section 
3.2.2. Diffraction data were collected from a 360° rotation of the crystal, with data 
collected every 0.5°, at a wavelength of 0.9537 Å. Diffraction data were collected 
from a single crystal grown in 28% (v/v) TacsimateTM pH 6.6 at a protein 
concentration of 24 mg.ml-1 (Figure 3.3).  
 
Figure 3.3: Crystallisation and diffraction of CysE apoenzyme. (a) Crystal grown using hanging 
drop and whisker seeding. Crystallisation condition: 26.25% (v/v) TacsimateTM pH 6.6, 24 mg.ml-1 
of protein. (b) example of CysE diffraction from crystal. (c) Close up of diffraction pattern from (b). 
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3.3.2 CysE data processing 
Data was indexed initially in space group P21, but was determined to have been 
incorrectly assigned using zanuda, (Lebedev & Isupov, 2014) from the CCP4 suite 
(Winn et al., 2011). The data was subsequently reindexed in space group P2 (based 
on zanuda output), integrated and scaled using XDS (Kabsch, 2010). Data was 
merged using AIMLESS from the CCP4 suite (Winn et al., 2011). AIMLESS was 
also used to generate a FreeR flag dataset for refinement and dataset quality 
statistics (Table 3.1). The CysE dataset had resolution to 2.01 Å.  Data quality 
statistics demonstrate that the quality of the data is good with parameters meeting 
the following data quality thresholds; CC1/2 ≥ 0.3 (0.917), I/σI ≥ 2.0 (3.5) and 
Rmerge ≤ 0.8 (0.490) and overall completeness ˃ 95% (100%) (values in highest 
resolution shell reported). Resolution was not cut back and data were used for 
downstream processing.  
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Table 3.1: Data collection statistics for CysE. Statistics for highest resolution shell are in brackets. 
Data statistics generated by AIMLESS and phenix.tableone. 
Data statistic Apostructure  
Space group P2  
Wavelength (Å) 0.953732  
Cell dimensions 
a/b/c (Å) 
α/β/γ (°) 
77.999/94.011/102.158 
 
90.000/91.285/90.000 
 
Mosaicity 0.05  
Monomers in 
asymmetric unit 
6  
Resolution range (Å) 46.93-2.01 (2.04-2.01) 
Numbers of observed 
reflections 
689243 (35091) 
Number of unique 
reflections 
97704 (4841) 
R
merge
 0.053 (0.490) 
Rpim 0.02259 (0.1943) 
CC (1/2) 0.999 (0.917) 
Mean I/σI 17.2 (3.5) 
Completeness 100.0 (100.0) 
Multiplicity 7.1 (7.2) 
Wilson B factor (Ang
2
) 
30.7  
 
3.3.3 Solving the structure of CysE 
There are homologous CysE structures in the PDB, some of these were identified 
to be potential candidates for molecular replacement with good sequence similarity 
( ≥ 30%) and conservation of secondary structural features (Figure 1.7 and Figure 
3.4). Using this information, we decided to use the CysE structure from Y. pestis 
(3GVD) as our search model for molecular replacement as it exceeded the minimum 
sequence requirements (57% sequence similarity) (Kim et al., 2006) and the 
majority of the structure had been built (96%).
  
7
2
 
 
 
Figure 3.4: ENDscript analysis of the secondary structure of CysE from N. gonorrhoeae. For each residue solvent accessibility and hydrophobicity is labelled below the 
sequence. Solvent accessibility is labelled “acc” and is rated in terms of “Blue” being accessible, “cyan” less accessible, “white” being completely buried, from solvent (red 
being not calculated). Hydrophobicity is labelled as “hyd” and is ranked as cyan being hydrophilic, purple being hydrophobic and white being neutral. Secondary structure 
elements are labelled in grey above the peptide sequence, with helices, β-strands, and β-turns, represented by linked loops, arrows and TT, respectively. Letters indicate non-
crystallographic interaction with chain denoted by letter. Refer to Appendix C.3. for chain labelling of the monomers in the ASU. Chain B was used for analysis. Figure 
generated using ENDscript 2.0 (Robert & Gouet, 2014).  
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The Mathew’s co-efficient was used to predict the number of monomers in 
asymmetric unit (ASU) (Matthews, 1968). The most likely number of monomer 
copies was determined to be six, calculated with a predicted molecular weight of 
31.5 kDa for CysE using Protparam, (section 2.2.4.2). For molecular replacement, 
the CysE monomer (3GVD) was used as a search model, with six monomers in the 
ASU (Phenix.phaser). Phaser found one solution, which had good TFZ and LLG 
scores of 37.3 and 5333, respectively (McCoy et al., 2007).  
Phenix.xtriage and AIMLESS were used to assess data quality and detection of 
crystal pathologies. There was strong evidence that the CysE dataset possessed 
translational non-crystallographic symmetry (tNCS), as indicated by the presence 
of a large (48%, p= 8.2*10-5) non-origin peak of the Patterson function. tNCS can 
lead to issues during refinement such as high R-values (Rwork/Rfree) (Read et al., 
2013). Therefore, the structure was refined with tNCS torsion-constraints using 
phenix.refine. The program also detected the presence of two ice rings, which are 
visible in Figure 3.3. Completeness in resolution shells 2.26-2.22 Å was noticeably 
lower compared to other low resolution shells (92 vs. 99%) (Appendix C.2.). Given 
that the level of data completeness was still reasonable (≥90%), no data was 
excluded from downstream analysis. 
The CysE model was built using the program autobuild.phenix. The program was 
supplied with the phenix.phaser output model and map, reflection file (with FreeR 
flag dataset) and the CysE amino acid sequence. Default settings were used 
(Appendix C.4.), with the exception of not placing waters in refinement and rebuild 
in place set to false. The latter step is to allow the program to edit the structure file 
sequence based on the sequence file, as well as build outside the model (if there is 
unmodelled density). The structure went through six iterative building rounds and 
three cycles of refinement. The resulting structure had a good Rwork/Rfree score for 
a starting model of 0.2413/0.28839. In the asymmetric unit, six monomers were 
built, with three packed forming a homotrimer, while two of the remaining 
monomers form two-thirds of a trimer, while the remaining monomer is outside of 
the trimer. The last trimer can be generated from the repeating crystal symmetry 
lattice (Appendix C.3.). The majority of each monomer was built (80%) by 
automated building using phenix.autobuild, however there was a large amount of 
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unmodelled density at both the N and C-terminal ends of each chain. The remaining 
unbuilt peptide sequence was manually built in COOT. 
3.3.3.1 Identification of active site ligand  
Visual inspection of the refined CysE model, revealed that the active site had 
unmodelled density that was too large to be water (Figure 3.5). Initially we screened 
200 compounds using phenix.ligandidentification (as per section 3.2.4.4), but this 
was unsuccessful. Using phenix.ligandFit we screened the physiologically relevant 
compounds L-serine and L-cysteine. Once fitted, the model and ligand were refined 
together using phenix.refine. Initially, both L-cysteine and L-serine fitted well, but 
after refinement, the Fo-Fc map indicated that there was still positive density 
present, and that the thiol and hydroxyl group did not have enough electron density 
to support the electron density map. Based on this we screened the buffer 
compounds malonate and D-malate present in our crystallisation condition (i.e. 
compounds present in TacsimateTM , Appendix C.1.). Malonate is a three carbon 
dicarboxylic acid, and fitted well initially, but there was clearly a side group present 
on the middle carbon. Finally, we fitted and refined with D-malate, and found that 
there was no positive or negative density present (Figure 3.5b), indicating a good 
fit. 
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Figure 3.5: COOT electron density maps for fitting of D-malate. (a) Map and model used for fitting 
ligands. (b) Refined map and model with D-malate. 2Fo-Fc map (blue mesh) is contoured to 1 σ and 
Fo-Fc map is contoured to 3 σ (green and red mesh). Green mesh = positive density, Red mesh = 
negative density. Active site residues Asp161, His162, Arg196, Gly189 and Asp96 are labelled. D-
malate is denoted as dark yellow sticks. Waters are denoted as red crosses. 
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3.3.4 Analysis of CysE structure 
Our final structural model for CysE has a final Rwork/Rfree of 0.1846/0.2174 (Table 
3.2). Structure and map files for the CysE model are listed under Appendix C.5. 
There was no density to support the N-terminal Hexahistidine-tag for any of the 
chains in the ASU, or the first two residues of each monomer. The overall structure 
of CysE is well built, with an average monomer length of 260 residues (260/272, 
96% built) (Appendix C.6.). The CysE monomer is composed of an N-terminal α-
helical domain (Met1-Phe144) and a unique left-handed parallel β-helix (LβH) 
(Gly145-Ile272) (Figure 3.4 and Figure 3.6,). The alpha helical domain consists of 
eight α-helices. The domain begins with a meandering loop (Lys3-Asp12). α1 helix 
spans from Leu13-Ala27. From α1 to α2 there is a sharp ≈ 180° turn, which aligns 
α2 (Pro29-Arg41) and α1, forming an antiparallel hairpin. After α2 an ≈ 90° turn 
occurs before α3 (Leu45-Leu57), breaking away from the α1 and α2 hairpin. After 
α3, there are two turns, lining up α4 (Val64-Ala74) to run antiparallel to α3. From 
α4 there is another turn before leading to α5 (Thr79-Arg95). After α5 a turn links 
to α6 (Tyr102-Tyr108). From α6 there is a turn before transitioning to α7 (Lys110-
Asp127) which is followed by the helix α8 (Lys130-Phe144), which then leads onto 
the beginning of the C-terminal domain.  
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Table 3.2: CysE final model quality statistics. Statistics generated by phenix.xtriage and 
phenix.tableone. 
Data statistic CysE 
Rwork 0.1818 
Rfree 0.2159 
No. of protein residues 1550 
Total number of non-hydrogen 
atoms 
12194 
Macromolecules 11465 
Ligands 54 
Solvent 675 
RMS      Bonds (Å) 
Angles (°) 
0.008 
1.018 
Average B value (Å)  38.74  
Macromolecules 38.64  
Ligands 34.97 
Solvent 40.86 
Ramachandran analysis 
 
No. of residues in favoured region 
(%) 
97.3 
No. of residues in allowed region 
(%) 
2.7 
No. of residues in outlier region 
(%) 
0.0 
Rotamer outliers (%) 0.09 
 
The C-terminal domain consists of a lefthanded parallel β (LβH) helix, consisting 
of 15 turns and five distinct coils. The helix contains six β-sheets: β1 (Leu158-
Asp161), β2 (Ile178-Leu181), β3 (Thr185-Gly187), β4 (Ile238 -Val241), β5 
(Lys246-Arg250), β6 (Lys246-Arg250) (Figure 3.6). The repeating turn-sheet-turn 
pattern is generated by repetition of a tandem hexapeptide repeat (Figure 1.7 and 
Figure 3.4). The only deviation from this repeat within the helix is between β3 and 
β4, which leads to the formation of an extended β-loop. This β-loop extends from 
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Gly191 to Arg199. This loop forms one half of the active site for CysE, and houses 
active site residues Arg196, His197, Gly188, where D-malate binds (Figure 3.6). 
The LβH ends at Pro244, after which the short C-terminal tail breaks away from the 
helix forming a small helix α9 (Pro255-Asp258). 
  
Figure 3.6: CysE monomer from N. gonorrhoeae. Protein amino-terminus is coloured blue and 
carboxyl-terminus is coloured red. All domains are labelled as well as the flexible C-terminal tail. 
Active site residues and the bound ligand D-malate are represented as sticks, with malate coloured 
yellow. Active site residues are coloured green and purple to match colour scheme in Figures 3.8 
and 3.9. Note active sites are shared across two monomers in the trimer explaining why active site 
residues are on opposing sides of the monomer. Figure generated in PyMOL. 
Chapter 3 
 
79 
The C-terminal tail adopts two conformations in our structure. For chains C and D 
(Appendix C.3), the tail loops upward against the side of the monomer, in the same 
manner as homologous CysE structures (Figure 1.8c) forming predominantly 
hydrophobic interactions, as well as a single hydrophilic interaction between the 
terminal amine group on Lys223 and the hydroxyl groups from tail residues Asp260, 
Gln261 and Asn262 (Figure 3.7b). For chains A, B, E and F, the tail extends 
outward away from the trimer and packs against neighbouring CysE monomers, by 
fitting into the groove where the C-terminal tail would bind (Figure 3.7c, Figure 
3.8a and Figure 3.9). We hypothesise this extended C-terminal conformation is 
formed from domain swapping.  
 
 
Figure 3.7: Comparison of the two C-terminal tail formations present in CysE. (a) Monomer with 
folded C-terminal tail. (b) Close up of C-terminal tail from (a) interacting residues are shown as 
sticks with hydrophobic residues coloured peach, polar residues coloured green and hydrophilic 
residues coloured magenta. (c) Monomer with the ‘domain swapping’ C-terminal tail. Images 
generated in PyMOL. 
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Figure 3.8: Analysis of the domain swapping C-terminal tail in the CysE monomers. (a) Monomer 
C-terminal domain swapped with monomer in adjacent hexamer. Non-domain swapped monomers 
in both hexamers have been removed for clarity. (b) COOT electron density map for domain 
swapped C-terminal tail. 2Fo-Fc and Fo-Fc map contoured at one and three σ, respectively. (c) 
Domain swapped monomers from (a), with non-interacting monomers removed. Images generated 
in PyMOL and COOT. 
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Domain swapping is where two proteins exchange identical structural segments 
with each other, forming a higher oligomeric conformation (Bennett et al., 1995). 
The domain swapped C-terminal chains are supported by electron density, for four 
chains (Figure 3.8b).  In domain swapped proteins there is often a hinge loop which 
is able to adopt a domain swapped conformation (Bennett et al., 1995). In CysE we 
see that the C-terminal chain deviates from the folded C-terminal conformation at 
residue Ser251 (Figure 3.9). The C-terminal tail extends away from the monomer 
from Ser251 to Pro255, and then mimics the interaction of the CysE folded C-
terminal tail from Ser256 to Gln264, as demonstrated by alignment of the 
blue/green C-terminal tail. 
 
Figure 3.9: Analysis of the domain swapped CysE C-terminal tail. Domain swapped monomer is 
coloured cyan. The folded C-terminal tail monomer denoted as green. Chain B is coloured cyan, 
chain C is coloured green. Hinge loop residues labelled and denoted as sticks. Image generated in 
PyMOL. 
For chains C and D, which have the folded C-terminal tail conformation, the 
monomers are likely capable of domain swapping but are unable to due to crystal 
packing. In Figure 3.10, the monomers with folded C-terminal tails (yellow/chain 
C and magenta/chainD) are horizontally displaced from monomers in the 
neighbouring hexamer (green), preventing the C-terminal tails from being able to 
physically reach the C-terminal binding region on the adjacent monomer and as a 
result are unable to undergo domain swapping.  
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CysE purifies as a hexamer during gel filtration chromatography (Figure 2.2), and 
SAXS analysis is also consistent with a hexameric protein (data collected by Dr 
Hicks and not shown), consistent with the majority of CysE homologues. We 
conclude that the extension of the C-terminal tail leading to domain swapping is an 
artefact of crystal packing and is not present when CysE is in solution. The C-
terminal tail is well built in this structure compared to the many CysE structures in 
the PDB (Olsen et al., 2004; Pye et al., 2004; Kumar et al., 2011).There are still 
eight residues missing from the C-terminal tail, but this tail has been reported to be 
flexible (Pye et al., 2004) and so is likely not visible in the crystal structure. 
 
Figure 3.10: Analysis of CysE monomers with no domain swapping. The image contained within 
the black box is a close up of one of the folded C-terminal monomers (yellow) amongst packed 
hexamers in the lattice. Here the symmetry generated monomer (green) and folded monomer are 
displaced vertically as a result of crystal packing.  
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3.3.4.1 Analysis of the CysE hexamer 
In the monomer, each LβH helix is shaped as a triangular barrel, which pack 
together to form a trimer with three fold symmetry (Figure 3.11a,b). The trimer has 
a height of 44 Å, and a width of 50 Å at the N-terminus and 48 Å at the C-terminus. 
The main interactions between monomers in the trimeric arrangement are 
hydrophobic interactions between the N-terminal helices α2 and α4 on adjacent 
monomers.  
The CysE hexamer is composed of a dimer of trimers and has three and two fold 
symmetry (Figure 3.11c). The CysE hexamer is 104.2Å long, with the same width 
dimensions of the trimer. The dimer of trimers forms through interaction of the N-
terminal domains between two trimers. A large portion of the trimer surface area is 
buried at the trimer-trimer interface, with 22410 Å2 buried out of a total hexameric 
surface area of 50460 Å2 (calculated as per section 3.2.4). The calculated free gibs 
energy for the dissociation (ΔGdiss) of the hexamer is 18.5 kcal/mol, demonstrating 
that the hexameric arrangement is thermodynamically stable. CysE has been 
confirmed to elute as a hexamer by gel filtration chromatography (Figure 2.2) This 
hexameric oligomeric state for CysE, has been demonstrated by Kumar et al. (2011), 
to vital for CSC formation. 
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Figure 3.11: Quaternary arrangement of CysE from N. gonorrhoeae. (a) CysE trimer. (b) Trimer 
rotated by 90°C. (c) Dimer of trimers, hexameric arrangement. Peptide chain is displayed as cartoon 
and D-malate is shown as yellow spheres bound in the active sites. Figure generated using PyMOL. 
3.3.4.2 The CysE active site 
Active sites are formed between each monomer in a trimeric arrangement, with six 
actives site per hexamer. Active site residues are distributed between neighbouring 
monomers (Figure 3.11, Figure 3.12 and Figure 3.14). These active site residues 
have been identified through sequence alignment (Figure 1.7) and are labelled in 
Chapter 3 
 
85 
Figure 3.13 and Figure 3.14. One half of the active site is on the β-extended loop 
(Arg196, His197, Gly188B, green) of one monomer, while the other residues 
(Asp96, Asp161 and His162,magenta) are situated on the linking turn between the 
α5 and α6 helices (Figure 3.12). Hydrogen bonds between D-malate and residues 
were determined using the measurement wizard tool in LigandPlot (Figure 3.14) 
and PyMOL (Figure 3.13).  
 
Figure 3.12: D-malate bound in the active site between two CysE monomers. D-malate and active 
site residues represented as sticks. Catalytic residues Asp147 and His162 are labelled. Figure 
generated using PyMOL. 
The Arg196 terminal amine and amide form strong hydrogen bonds (2.7 and 2.8 Å) 
with the C1 carboxylic group (Figure 3.14). The α-hydroxyl group interacts with a 
water (3.1 Å), which is co-ordinated by negatively charged groups from Asp96 and 
Asp161. The C4 carboxylic acid group is wedged between two flanking histidines, 
His162 and His189. The carboxyl group is bent away from catalytic residues 
His162 (3.6 Å, distance not shown), and hydrogen bonds to the Nϵ2 from the 
imidazole ring of His197 (2.8 Å) and peptide backbone amide of Gly188 (2.6 Å) 
(Figure 3.13 and Figure 3.14).  
Chapter 3 
 
86 
 
Figure 3.13: LigPlot representation of D-malate interaction in CysE active site. Only hydrophobic 
interactions between catalytic triad residue His162 and D-malate are observed. Figure created using 
LigPlot+ . 
The formation of the catalytic triad is present in the N. gonorrhoeae CysE structure 
with the co-ordination and interactions of D-malate and active site residues 
comparable to those seen with L-cysteine bound in the E. coli CysE structure 
(Figure 3.14b, c). The major differences regarding interactions is between the 
carboxylic acid group and the flanking histidine residues. In E. coli, the thiol group 
from L-cysteine interacts with both of these histidine residues. 
Catalytic triad residues, His162 and Asp147, are equivalent to His158 and Asp143 
in E. coli (1T3D) (Figure 3.14). Likewise, the N. gonorrhoeae active site residues 
Asp161, Asp96, Arg196, His197 are equivalent to Asp153, Asp88, Arg188 and 
His189, respectively, in E. coli. The majority of hydrophilic interactions between 
N. gonorrhoeae CysE and D-malate are the same as E. coli CysE (1T3D) and L-
cysteine. The only differences are the interactions between the active site histidines 
and the terminal carboxylic acid/β-thiol group (N. gonorrhoeae/E. coli). In our 
CysE structure the carboxylic group is bent away from His162, and instead is co-
ordinated to the amine of the His197 imidazole ring and the peptide amine group of 
Gly187 on the Chain C side of the active site. 
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Figure 3.14: Comparison of active sites from N. gonorrhoeae with D-malate bound and CysE with 
L-cysteine bound from E. coli (1T3D). D-malate, L-cysteine and active site residues represented as 
sticks. (a) Chain A and chain B active site residues have been coloured pink and green to represent 
belonging to each adjacent monomer. Malate is coloured purple. (b) Chain A and chain B active site 
residues have been coloured pink and green to represent belonging to each adjacent monomer. 
Cysteine is coloured purple. (c) Overlay of CysE with 1T3D. Dashed lined represent hydrophiclic 
interactions. Bond distances are in Angstroms. Figure created using PyMOL. 
Equivalent residues involved in CoA binding, from the soybean CysE structure 
were identified using structural alignment in PyMOL. Here, residues Ala215, 
Ala233 and Gly195, are equivalent to residues Ala208, Ala226 and Gly188 from N. 
gonorrhoeae (Figure 3.15). Superposition of the CysE structure from soybean 
complexed with CoA (4N6B) and our CysE structure, show a high degree of 
similarity (r.m.s.d = 0.682). We subsequently modelled CoA into the active site of 
our CysE structure, to examine CoA interactions. CoA binds in the cleft between 
neighbouring monomers (Figure 3.15). The major interactions between CoA and 
the CysE monomer are hydrogen bonding interactions. On one monomer, the amine 
groups from Ala208 (2.8Å) and Ala226 (3.1Å), hydrogen bond with hydroxyl 
groups of the CoA pantothenic arm. Given that there are no structures with acetyl 
CoA bound in the active site of CysE and given that CoA is isostructural for acetyl 
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CoA, the interaction between CysE and CoA presented here are presumed the same 
as interactions between CysE and acetyl CoA. 
On the neighbouring monomer the Gly188 hydroxyl group hydrogen bonds to the 
amine located on the pantothenic arm of CoA. Upon closer examination of our 
structure with CoA modelled in the active site, the thioester group of CoA is present 
in the active site and located in close proximity to the catalytic His162 (Figure 3.14) . 
If acetyl CoA were bound in CysE where CoA is modelled, the acetyl group would 
be able to participate in the transferase reaction.  
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Figure 3.15: Overlay of CysE with CysE and CoA from soybean (4N6B). Soybean CysE is coloured 
blue and CoA is denoted as orange sticks. CysE trimer from N. gonorrhoeae is coloured yellow, 
magenta and green. Hydrogen bonding residues are labelled for Ala208, 226 and Gly188. 
Hydrophilic interactions are denoted as dashed yellow lines. All distances measured in Angstroms. 
Image generated in PyMOL.  
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While the Ramachandran analysis reported no outliers, active site residues His162 
and Arg196, as well as Ala163, were consistently in the allowed region, but not 
favoured region, for all six monomers (Figure 3.16), suggesting that the residues 
are in an energetically strained conformation. This strained conformation for these 
active site residues is supported by electron density (Figure 3.5) and in keeping with 
observations from studies of CysE homologue from H. influenzae (Olsen et al., 
2004). Given that these residues are part of the active site, this conformation is 
likely related to catalysis. 
 
Figure 3.16: Ramachandran analysis of non-proline/glycine residues from the CysE structure. Dots 
represent the phi and psi angles for a single residue. Favoured, allowed and disallowed regions are 
outlined on the graph. Favoured regions are within the innermost blobs (dark red). Allowed regions 
is the area between the innermost and outermost blobs (pink). Disallowed region is the area outside 
the outermost blobs (light pink/white). Analysis was generated using Molprobity. 
Ligand soaks were performed with CysE crystals with substrates acetyl CoA and 
L-serine as per section 3.2.1.8. Datasets were collected for each substrate 
respectively, but intial analysis indicated that neither L-serine nor acetyl CoA were 
present at their respective substrate binding sites. Futthermore, deterioration of 
crystal quality was visible during soaks and was confirmed through smearing of 
diffraction spots (data not shown). Based on these results, future attempts to obtain 
the crystal structure of CysE bound to substrate will be through co-crystallisaiton.  
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Attempts were made to co-crystallise substrates L-serine, acetyl CoA and inhibitor 
L-cysteine with CysE (as per section 3.2.1.4). However, we found that our 
crystallisation drops were mainly precipitate, and any crystals that formed were 
determined by X-ray diffraction to be small molecule compounds, being most likely 
the ligand added. Further optimisation of the crystallisation conditions will be 
carried out. 
3.3.5 Formation of the cysteine synthase complex 
Cloning, expression and purification of CysK with and without the PLP cofactor 
was carried out by Dr Joanna Hicks as per section 2.3. Both CysE and CysK were 
purified using IMAC and gel filtration chromatography as per section 2.2.4., using 
the same IMAC buffers as previously mentioned (section 2.2.4) and a modified gel 
filtration buffer (50 mM Tris pH 8.0, 200 mM NaCl). Both proteins were purified 
individually using gel filtration chromatography, using an ENrich 650 column, for 
use in CSC experiments. 
CysE was shown to have an elution volume of 12.56 ml, consistent with a CysE 
hexamer, and is in keeping with results from section 2.3.1 (Figure 3.17a). The 
elution profile of CysK purified in the absence of PLP (Figure 3.17b) presents as 
two peaks, at 9.5 and 14.35 ml, with the latter of an approximate molecular weight 
of 47 kDa (calculated as per section 2.2.4.4), consistent with a CysK dimer. The 9.5 
ml peak occurs before the void volume of the column (10.56 ml) and is most likely 
aggregated protein. CysK purified in the presence of PLP shows little aggregated 
protein in the column void volume and elutes as a single peak at 14.6 ml consistent 
with a dimer (Figure 3.18b), with a small peak eluting at 18.55 ml, likely 
corresponding to free PLP. CysE and CysK proteins purified in the expected 
multimeric forms of a hexamer and dimer, respectively (Figure 3.18a, b). It is 
important to confirm and check the stoichiometries of the two proteins that 
constitute the CSC, prior to attempting to form the CSC. 
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To form the complex we trialled combining CysE and CysK at monomeric molar 
ratios (CysE:CysK) of 1:1 (CysK purified in the absence of PLP) and 3:2 (CysK 
purified with PLP) and incubating for 15 minutes on ice. A sample was removed 
for native-PAGE gel electrophoresis before loading onto a gel filtration column 
(Enrich 650).  
No elution peak corresponding to the CSC was observed on the gel filtration 
chromatograms. Each shows only two peaks, corresponding with a CysE hexamer 
and CysK dimer, respectively (Figure 3.17c and Figure 3.18c). Based on 
observations from homologous CSCs (Benoni et al., 2017b), the CSC is composed 
of one hexamer and two CysK dimers, and for N. gonorrhoeae the CSC would have 
a predicted molecular weight of ~ 332 kDa. This would correspond with a peak 
with an elution volume of 11.9 ml, which is absent from both Figure 3.17c and 
Figure 3.18c.  
 
Chapter 3 
 
93 
  
Figure 3.17: Gel filtration chromatogram of CysE, CysK and cysteine synthase complex formation 
attempt without PLP. (a) Gel filtration chromatogram of CysE. (b) Gel filtration chromatogram of 
CysK (b). (c) Cysteine synthase complex attempt, 1:1 CysE:CysK. All peaks are labelled with 
elution volumes. 
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Figure 3.18: Gel filtration chromatogram of CysE, CysK and cysteine synthase complex formation 
attempt with PLP. (a) Gel filtration chromatogram of CysK with PLP. (b) Gel filtration 
chromatogram of CysE. (c) Cysteine synthase complex attempt, 3:2 CysE:CysK. All peaks are 
labelled with elution volumes. 
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The lack of CSC formation was confirmed by native-PAGE gel electrophoresis 
(Figure 3.19). Both CysE and CysK stocks were ran alongside the CSC mixture for 
comparison. CysE runs as a single band near the top of the native-PAGE gel, 
whereas for CysK there are five thin bands that have migrated halfway through the 
gel (Figure 3.19). It is not clear why five bands are present, but these bands are 
likely differently charged forms of CysK, which have migrated at different rates 
during electrophoresis. Different bands could also represent PLP-bound and 
unbound forms of CysK. The CSC mixture has bands on the native-PAGE gel that 
are equivalent to the individual CysE and CysK samples, as would be expected, 
however there are no extra bands present. If a small amount of CSC had formed, 
we would expect an extra band not present in the CysE and CysK lanes to present 
in the CSC mixture. These results from native-PAGE gel electrophoresis confirm 
the gel filtration chromatography results, that the CSC was not formed.  
 
Figure 3.19: Native-PAGE gel electrophoresis of the 3:2 cysteine synthase complex formation 
attempt with PLP. (a) Native-PAGE gel electrophoresis of CysE, CysK and CSC. L= Precision Plus 
Ladder. CysE protein bands are labelled with blue arrows, CysK protein bands are labelled with 
green arrows, and CSC is highlighted in orange. Molecular weights of Precision Plus Protein 
Standards (L) in KDa are not labelled as standards could not be visualised. 
The cysteine synthase complex is well conserved across bacterial and plant species, 
but there are exceptions. The most well studied example is from the enteric 
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protozoan, E. histolytica. Here authors demonstrated using peptide binding assays 
that although the CSC could not form, the C-terminal CysE fragment could bind to 
CysK from E. histolytica. The inability of the CSC to form was attributed to the 
rare trimeric conformation of CysE (Kumar et al., 2011). CysE from 
N. gonorrhoeae exists as hexamer and includes residues essential for CSC 
formation, including the C-terminal tail isoleucine residue (Huang et al., 2005), and 
suggesting that it should form the CSC.  
One possible explanation for why we could not form the CSC, is the presence of 
O-acetylserine. O-acetylserine at millimolar concentrations (10 – 1000 mM), 
dissociates  the CSC (Benoni et al., 2017a). O-acetylserine is a common metabolite 
in E. coli (Sajed et al., 2015), and so it is possible that O-acetylserine from E. coli 
expression strain BL21(DE3) could co-purify with CysK or CysE, and prevent 
formation of the CSC. However, this can be ruled out as O-acetylserine, has been 
shown to be unstable at pHs greater than 7.6 (Kredich & Tomkins, 1966), where it 
will non-enzymatically form the isoform N-acetylserine, which is unable to bind to 
CysK (Kredich & Tomkins, 1966). Given that the purification of CysK was 
conducted at room temperature in buffers with a constant pH of 8.0, there was likely 
no O-acetylserine present, and can be ruled out.  
It is possible that the CSC forms in N. gonorrhoeae, but the rate of formation might 
be substantially slower than other CSC complexes. Benoni et al. (2017b) were able 
to form the E. coli CSC using nanomolar concentrations of CysE (7 nM) and CysK 
(23 nM) (monomer concentrations). Formation of the CSC for E. coli has been 
reported to have a dissociation constant (Kd) of 5 nM (Benoni et al., 2017a). This 
value suggests that the CysE and CysK subunits have a strong affinity for each other 
and the formation of the CSC is strongly favoured. It was assumed when planning 
the CSC experiments in this research, that the CysE and CysK from N. gonorrhoeae 
would have a similar affinity and form the CSC. We have demonstrated that even 
when using more concentrated stocks (micromolar) of CysE and CysK, we were 
unable to form the CSC. To investigate this theory, future work will involve 
incubating the CSC mixture for longer periods of time and trial a low CysE/CysK 
ratio (1:10 or 1:100) to increase the chances of CSC formation.  
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It is possible that the CSC is unable to form in N. gonorrhoeae. The evolutionary 
advantage for organisms that have lost the ability to form the CSC would be that 
CysK activity is no longer inhibited, which leads to increased L-cysteine production 
and gene expression of sulphate assimilatory genes would be subsequently down 
regulated, due to unregulated consumption of O-acetylserine by CysK. In this 
research we have shown that CysE from N. gonorrhoeae is sensitive to feedback 
inhibition by L-cysteine (Chapter 2). Given that N. gonorrhoeae has a high demand 
for cysteine, primarily for the production of large amounts of reducing compounds, 
like glutathione (Seib et al., 2006), there might be an advantage to not being able 
to form the CSC. However, further investigation and method optimisation is needed 
before we can fully rule out CSC formation. 
One possibility is that the lack of CSC formation is linked to the inability of 
N. gonorrhoeae to reduce sulphate to sulphide, and that two of the deleted genes 
from this pathway would be under operon control by the transcriptional regulator 
CysB. Sequence alignments by Hicks and Mullholland (2018) demonstrated that 
the OASS present in N. gonorrhoeae has the greatest homology to the OASS-A 
isoform (CysK). This isoform utilises sulphide as a thiol donor, whereas OASS-B 
isoform (CysM) utilises directly imported thiosulphate. Given that CysK is able to 
form the CSC, while CysM cannot (Zhao et al., 2006), it would be expected that 
we would be able to form the CSC in N. gonorrhoeae. However, biochemical 
characterisation studies of CysK from N. gonorrhoeae are required to investigate 
this further. 
3.4 Conclusions & future directions 
We have obtained a high-resolution structure of CysE from N. gonorrhoeae at a 
resolution of 2.01 Å. The structure is composed of two domains: an N-terminal 
α-helical domain and a C-terminal LβH domain. We describe the first evidence of 
a domain swapping in a CysE structure, where the flexible C-terminal tails domain 
swap with neighbouring monomers. In the active site, D-malate is bound and 
interacts through extensive hydrogen binding with the active site residues.  
One remaining challenge is to obtain a co-crystallised structure of CysE and its 
substrates. Co-crystallisation will be further optimised for substrates L- serine and 
acetyl CoA. These substrate-protein structures will provide essential information 
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on the residues needed for substrate binding and allow us to screen inhibitors to 
target these substrate binding sites. The tentative screening of two other CysE 
datasets obtained from crystals grown in TacsimateTM, all have D-malate bound in 
the active site. For future crystallisation attempts, a new crystallisation condition 
will be optimised to prevent the interference by D-malate. 
CysE active site residues are conserved in our CysE structure. Inspection of the 
active site shows conservation of the 3D arrangement around our buffer compound 
D-malate. The arrangement of the catalytic triad residues, His162 and Asp147 with 
L-serine, suggests that CysE from N. gonorrhoeae shares the same chemical 
mechanism as other CysE homologues.  
We are the first to demonstrate evidence of domain swapping for a CysE structure. 
The C-terminal tail, which is involved in the formation of the CSC, was able to 
domain swap with the C-terminal tail on a neighbouring monomer in the crystal 
lattice. Although this is an artefact of crystallisation, this provides some insight into 
the degree of flexibility of the C-terminal tail and the residues required for cysteine 
synthase complex formation. 
Attempts to form the CSC with CysE and CysK from N. gonorrhoeae were 
unsuccessful, but we will continue this research and explore other methods of 
measuring CSC formation. To confirm whether the CysE C-terminal tail can bind 
to CysK, we will use a fluorometric-based peptide binding assay using a 
decapeptide that mimics the C-terminal tail (Campanini et al., 2005). We will also 
trial the addition of sulphide, as it has been shown to promote the reassociation of 
the CSC in CysE homologues (Wirtz & Hell, 2006), and may help with CSC 
formation.  
The CysE structure presented here is a significant step towards developing 
inhibitors for CysE. However, for computational inhibitor screening high resolution 
structures with substrates bound are needed. If co-crystallisation of CysE and each 
substrate is unsuccessful, we can dock the substrates L-serine and acetyl CoA 
(based on other CysE structures) into our apo structure for inhibitor screening. The 
apo structure is extensively built (96%) and is solved at a high resolution (2.01 Å). 
Promising inhibitors identified using this method, will be ordered and tested using 
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the inhibition assays developed during this thesis. The ultimate goal would be to 
identify a potent inhibitor that shows good specificity for CysE. 
While outside the scope of this master’s thesis, future research will characterise 
CysK from N. gonorrhoeae. Dharavath et al. (2017) demonstrated that Brucella 
abortus was unable to form the CSC, even though CysE had C-terminal residues 
shown to be important for CSC formation. This was attributed to two CysK residues 
occupying the active site, preventing the binding of the C-terminal tail from CysE. 
Hence, characterising CysK may reveal any structural differences in CysK that 
could explain why we were unable to form the CSC in N. gonorrhoeae.
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4 Chapter 4  
Conclusions and Future Research 
N. gonorrhoeae is the causative organism of the sexually transmitted infection, 
gonorrhoea. Over decades of antibiotic use the rapid emergence of antibiotic-
resistant strains has created a demand for new antimicrobial treatments (Wi et al., 
2017). The targeting of amino acid biosynthesis is a promising new field of 
antimicrobial research. The cysteine biosynthetic pathway has been shown to be 
important for pathogenicity and virulence in Neisseria species.  
N. gonorrhoeae encounters oxidative stress throughout pathogenesis. Furthermore, 
the ability of N. gonorrhoeae to spread to new hosts hinges on the ability of 
gonorrhoea to survive oxidative stress from commensal Lactobacilli in the 
urogenital tract and within the phagosome of a neutrophil (Hill et al., 1985; Seib et 
al., 2006). The ability to mitigate these stressors relies on reducing systems to 
mitigate these host derived oxidative stresses. Given that L-cysteine-derived 
compounds are necessary for the synthesis of antioxidants, including glutathione, 
as well as essential cellular compounds such as CoA, iron-sulphur cluster proteins, 
the pathway for de novo synthesis of L-cysteine is an ideal target for developing 
new treatments for N. gonorrhoeae. However, the function and regulation of 
cysteine synthesis is poorly understood in N. gonorrhoeae. In this thesis we have 
biochemically and structurally characterised one of the key cysteine biosynthetic 
enzymes, CysE. 
CysE is a serine acetyltransferase that catalyses the first step in cysteine 
biosynthesis. CysE catalyses the acetylation of L-serine, forming O-acetylserine, 
which then undergoes a condensation reaction with sulphide via O-acetylserine 
sulfhydrylase (CysK), to form L-cysteine (Pye et al., 2004). Multiple levels of 
regulation act on the sulphur assimilation and cysteine biosynthetic pathways in 
response to sulphur flux (Wirtz et al., 2012). This is primarily carried our via the 
feedback inhibition of CysE by L-cysteine and formation of the CysE:CysK 
cysteine synthase complex (CSC) (Benoni et al., 2017b). 
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In this thesis, we have successfully characterised the catalytic activity of CysE from 
N. gonorrhoeae. We show CysE has serine acetyltransferase activity, with 
Michaelis constants (KM) of 2.58 and 0.152 mM, for L-serine and acetyl CoA, 
respectively, which are comparable to values seen for other CysE homologues. 
These differences in enzyme affinity for each substrate reflects the intracellular 
concentrations of these substrates in the cell (Sajed et al., 2015) We also 
demonstrate the first evidence of substrate inhibition by acetyl CoA for a CysE 
enzyme. Interestingly, substrate inhibition by L-serine for CysE is well documented. 
The reason why substrate inhibition is present for acetyl CoA instead of L-serine, 
could be due to the presence of an ordered mechanism, similar to that seen for CysE 
from H. influenzae (Johnson et al., 2004). 
We have solved the structure of CysE from N. gonorrhoeae FA1090 at a high 
resolution of 2.01 Å. In our structure, key active site residues, His162 and Asp146, 
are conserved. D-malate is bound in the active site and interacts with the same 
residues as the inhibitor L-cysteine. These residues and the co-ordination of 
L-serine/L-cysteine (or the isostructural compound D-malate in our structure) 
confirm formation of the catalytic triad, the essential mechanism of CysE (Pye et 
al., 2004). We present the first CysE structure to show domain swapping. Here we 
observed the swapping of the C-terminal tail with neighbouring monomers in the 
crystal lattice. While this is an artefact from crystallisation, this demonstrates the 
flexibility of the C-terminal tail, which is thought to be essential for the formation 
of the cysteine synthase complex (Huang et al., 2005). 
We were unable to form the cysteine synthase complex using purified CysE and 
CysK from N. gonorrhoeae. Based on the presence of the essential isoleucine at the 
end of the C-terminal tail of CysE (Huang et al., 2005), and confirmation of the 
flexible nature of the C-terminal tail, we expected the CSC to form. The primary 
purpose of the CSC is to promote the upregulation of the sulphate assimilation 
pathway in response to low sulphate conditions (Wirtz & Hell, 2006; Kumar et al., 
2011). Given that N. gonorrhoeae has lost the ability to reduce sulphate to sulphide 
but is able to grow using thiosulphate as a sole sulphur source (Le Faou, 1984), 
there may be no advantage to forming the CSC. The CSC also had drawbacks such 
as halting L-cysteine formation (via inhibition of CysK) (Huang et al., 2005; 
Benoni et al., 2017b), under low sulphate conditions, therefore in N. gonorrhoeae 
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the lack of formation of the CSC would allow the continuous production of L-
cysteine synthesised from thiosulphate. In E. histolytica, CysE is unable to form the 
CSC complex with CysK (Kumar et al., 2011). This lack of formation was 
attributed to CysE conformation of a trimer and not a hexamer and the C-terminal 
tail, even though a terminal isoleucine is present. The intracellular demands for this 
protozoan are quite high considering its inability to store glutathione, instead 
relying on high concentrations of cysteine to act as a reducing system (Kumar et al., 
2011). N. gonorrhoeae differs here as it documented to have high concentrations of 
glutathione, but both organisms would require large amounts of L-cysteine to 
maintain these high metabolite concentrations. Given that cysE is an essential gene 
in N. gonorrhoeae, even when cysE deletion strains are cultured in the presence of 
L-cysteine (Remmele et al., 2014), suggests that de novo cysteine synthesis is 
essential for N. gonorrhoeae and that L-cysteine/cystine importation alone is not 
enough to meet the L-cysteine demands of N. gonorrhoeae. 
One interesting difference between the CSC forming CysE proteins from other 
bacteria and CysE from N. gonorrhoeae is substrate inhibition. It is well 
documented that the CSC forming CysE proteins are subject to substrate inhibition 
by L-serine (Kredich & Tomkins, 1966; Johnson et al., 2004), whereas we show 
CysE from N. gonorrhoeae experiences acetyl CoA inhibition (at concentrations of 
acetyl CoA above physiological concentrations). The formation of CSC also 
increases CysE activity via increasing the Ki / KM for L-serine (Benoni et al., 2017b), 
The mechanism for this is unclear and given that there is no crystal structure for the 
CSC, it is hard to determine if CysE in the CSC undergoes conformational changes 
that could explain this difference in L-serine affinity. Considering CysE from N. 
gonorrhoeae and CysE in the CSC do not experience L-serine inhibition, CysE 
from N. gonorrhoeae may have slight structural differences that are more like the 
CysE conformation in the CSC, which would prevent L-serine substrate inhibition.  
An alternative reason for the inability of CysE and CysK from N. gonorrhoeae to 
form the CSC is the CysK (OASS-A) protein. The OASS identified in 
N. gonorrhoeae has higher sequence homology to CysK (can form the CSC) 
(Benoni et al., 2017b) and not the thiosulphate utilising isoform CysM (cannot form 
the CSC) (Nakamura et al., 1983; Tai et al., 1993). Given that N. gonorrhoeae can 
grow on thiosulphate as a sole sulphur source (Le Faou, 1984), CysK must be able 
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to utilise thiosulphate as a thiol donor. It is possible that CysK may share some 
characteristics of CysM, including the inability to form the CSC. CysK remains 
uncharacterised in N. gonorrhoeae, however, biochemical and structural analysis 
may provide insight into the formation of the CSC and regulation of cysteine 
synthesis in N. gonorrhoeae. 
To confirm CysE and CysK from N. gonorrhoeae cannot form the CSC, future 
efforts will employ a more rigorous method of measuring CSC formation using a 
fluorometric assay, monitoring emission of the CysK co-factor, PLP (Campanini et 
al., 2005). Sequence alignments show that residues essential for CysE binding to 
the CysK active site are present in the ten carboxyl terminus residues from CysE, 
suggesting that CysE would be able to form the complex. The fluorometric assay 
to monitor binding of CysE to CysK will also be used to investigate the CSC, using 
a CysE C-terminus mimicking peptide.  
While the cysteine biosynthetic and sulphate assimilation pathway is regulated 
directly by sulphur availability, cysE is the exception as it is constitutively 
expressed (Jones-Mortimer et al., 1968). To confirm the essentiality of cysE in N. 
gonorrhoeae, a cysE knockdown strain in N. gonorrhoeae strain, MS11 will be 
created. The promoter of cysE in N. gonorrhoeae MS11 will be replaced with a 
tetracycline-inducible promoter. This will confirm essentiality by in vitro growth 
experiments in the presence and absence of tetracycline.  
Neisseria meningitidis is the leading cause of bacterial meningitis, with New 
Zealand having some of the highest rates globally (Lopez & Sexton, 2013). There 
is a high level of sequence similarity 97% between CysE homologues from 
N. gonorrhoeae and N. meningitidis. CysE is also essential for growth of 
N. meningitidis (Capel et al., 2016). Given the importance of these two pathogenic 
Neisseria species and the sequence homology between CysE homologues, the 
results of this thesis are broadly applicable to CysE from N. meningitidis.  
The results presented in this thesis represent a major leap forward in our 
understanding of cysteine biosynthesis in N. gonorrhoeae. These results are also 
the basis for future work to identify potential CysE inhibitors using computational 
inhibitor screening. Computational inhibitor screening streamlines the inhibitor 
discovery process via the ability to screen hundreds of thousands of inhibitors 
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versus thousands of inhibitors using typical in vitro laboratory based screening. 
However, computational inhibitor screening relies on a detailed understanding of 
kinetic mechanism and high-resolution protein structures with and without 
substrates bound. Ongoing research based on the crystallisation of CysE presented 
here will attempt to obtain CysE structures with L-serine, acetyl CoA and 
L-cysteine bound respectively. However, if this is unsuccessful the high-resolution 
structure of CysE presented here can be used to dock substrates and inhibitors for 
use in computational inhibitor screening. Promising inhibitor compounds can be 
tested in vitro using assays developed in this thesis. Overall, this research has 
contributed to a greater understanding of a previously uncharacterised essential 
enzyme for a key metabolic pathway within N. gonorrhoeae and paved the way for 
the development of new inhibitors targeting the promising new antimicrobial target 
in N. gonorrhoeae, CysE. 
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Appendices 
Appendix A: Cloning information for CysE 
A.1. Sequences for CysE (NG0_1423) 
CysE (NG0_1423) | Neisseria gonorrhoeae (strain ATCC 700825 / FA 1090) 
location  
CysE FA1090 nucleotide sequence | NC_022240.1| NC_022240.1 
(1458601..1459419) 
ATGAAAAAAAACCATTTGAACACAACCGGTTTCGACCTCTGGCACACC
ATCCGCGAAGAAACCGCGGCCGCTGCCGCCGCCGAACCGATGCTGGC
AAGTTTTTTGCACCAAACCGTGTTGCGCCACGAGTCCCTCGGCTCCGTC
CTTGCCTACCACCTTTCCAGCAAACTCGGCAGCCCGATTATGGACGTG
CGCGCGCTGTTTGAAATTTACCAGCAGGCATTGGGCAGCGACACCCAA
ATCAGCAAATGTGTCGAAGCAGACTTAAAAGCCATCTACGAACGCGAT
CCCGCCTGCGACGAATATTCGCTGCCGCTTTTATATTTCAAAGGCTTCC
ACGCGATTCAGGCACACCGCATCAACCACCGGCTGTATCTCGACGGAC
GCAAAACGCTGGCGTATTTCCTACAAAACCGTATGTCCGAAGTATTCG
GCGTGGACATCCATCCCGCCGCCCGTTTAGGATACGGGCTGATGCTCG
ACCACGCCACCGGCTTTGTTGCCGGAGAAACCGCCGTGTTGGGCAACA
ATATTTCGATTTTGCACGGCGTAACGCTCGGCGGTTCGGGCAAAGAAG
GCGGCGACCGCCACCCCAAAATCGGCGACGGCGTGATGATCGGCGCA
AACGCCTCGATATTGGGCAATATCCGCATCGGCAGCAATGCCAAAATC
GGCGCGGGCAGCGTCGTGGTTTCAGACGTGCCGCCGTCCATCACGGTT
GTCGGCGTACCCGCCAAACCCGTGGCGCGATCGCTCAAAACCCCGTCG
GCGGATATGGATCAAAATATCCAGTTTGCCGAAATCGACTTTATGATT
TGA 
 
CysE peptide sequence| 29.3 kDa| EC:2.3.1.30 
MKKNHLNTTGFDLWHTIREETAAAAAAEPMLASFLHQTVLRHESLGSVL
AYHLSSKLGSPIMDVRALFEIYQQALGSDTQISKCVEADLKAIYERDPACD
EYSLPLLYFKGFHAIQAHRINHRLYLDGRKTLAYFLQNRMSEVFGVDIHP
AARLGYGLMLDHATGFVAGETAVLGNNISILHGVTLGGSGKEGGDRHPK
IGDGVMIGANASILGNIRIGSNAKIGAGSVVVSDVPPSITVVGVPAKPVARS
LKTPSADMDQNIQFAEIDFMI 
CysE peptide sequence | N-terminal HexaHis-tag and leader sequence (underlined) 
293 residues| 31.6/189.6 kDa (monomer/hexamer)| theoretical pI 6.83 
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MGSSHHHHHHSSGLVPRGSHMMKKNHLNTTGFDLWHTIREETAAAAAA
EPMLASFLHQTVLRHESLGSVLAYHLSSKLGSPIMDVRALFEIYQQALGSD
TQISKCVEADLKAIYERDPACDEYSLPLLYFKGFHAIQAHRINHRLYLDGR
KTLAYFLQNRMSEVFGVDIHPAARLGYGLMLDHATGFVAGETAVLGNNI
SILHGVTLGGSGKEGGDRHPKIGDGVMIGANASILGNIRIGSNAKIGAGSV
VVSDVPPSITVVGVPAKPVARSLKTPSADMDQNIQFAEIDFMI 
pET28b description 
Vector Description 
pET28b E.coli expression vector, 5368 bps, N-
terminal thrombin cleavage site, 
Kanamycin resistance, C and N-
terminal His-tags, T7-promoter. 
GMO approval numbers: 
E. coli: GMD101146 
 N. gonorrhoeae: GMD102338 
A.2 Luria Bertani (LB) Agar (1 L) 
Combine the following: 
5 g Peptone 
10 g NaCl 
5 g Yeast extract 
5 g Agar 
1 L of distilled water 
Autoclave at 121°C before use. 
LB Broth 
Same method as LB agar, but no addition of agar. 
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Appendix B: Protein purification and kinetic 
information 
B.1. Purification buffers for CysE kinetics and crystallography 
 Chemical Composition 
Lysis buffer 50 mM Tris (pH 8.0) 
200 mM NaCl 
20 mM imidazole  
Elution buffer 50 mM Tris (pH 8.0) 
200 mM NaCl 
1 M imidazole 
Gel filtration buffer 50 mM Tris (pH 8.0) 
100 mM NaCl 
 
SDS-PAGE and native-PAGE gel buffers compositions 
Quenching buffer (Q4)  
250 mM Tris (pH 6.8) 
20% glycerol (w/v) 
4% SDS (w/v) 
10% beta-2-mercaptoethanol (w/v) 
0.025% bromophenol blue (w/v) 
Tris-glycine SDS buffer 
25 mM Tris (pH 8.5) 
250 mM glycine 
0.1% SDS (w/v) 
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Fairbanks staining solution 
0.05% coomasie blue 
25% isopropanol 
10% acetic acid 
Destaining solution 
10% acetic acid  
B.2. Gel filtration calibration curve for ENrich 650 
 
Calibration curve for gel filtration column Enrich650. Calibration curved was used to calculate the 
approximate molecular weight and oligomeric state of CysE. Column was calibrated in 50 mM Tris 
(pH 8.0), 200 mM NaCl. 
B.3. Raw data used in method optimization, Michaelis Menten and inhibition 
assays 
Link to google drive folder: 
https://drive.google.com/drive/folders/1lOYqVibWfbxrQQ3OePha1swaKVvIH_2
5?usp=sharing 
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B.4. Initial enzyme concentration trials. 
 
Monitoring CysE activity via depletion of total absorbance at 232 nm over time with varying 
concentrations of enzyme. Final enzyme concentrations trialled 0.00156, 0.0031 and 0.0625 mg.ml-
1.  Data plotted here was divided by -1 (to get rate of O-acetylserine (product) formation, section 
2.2.1.8), to generate plot in Figure 2.3a. 
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Appendix C: Crystallisation and Structure solving 
information 
C.1. TacsimateTM composition (100% (v/v), pH 7.0) - HR2-755 
1.8305 M Malonic acid 
0.25 M Ammonium citrate tribasic 
0.12 M Succinic acid 
0.3 M DL-Malic acid 
0.4 M Sodium acetate trihydrate 
0.5 M Sodium formate 
0.16 M Ammonium tartrate dibasic 
C.2. Statistics by resolution shell  
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Dataset completeness for each resolution shell. Values generated by phenix.refine. 
C.3. Contents of the asymmetric unit for CysE. 
 
Contents of the asymmetric unit for CysE model. Space group P2. Waters are represented as red 
crosses. Ligand D-malate is bound in the active site and is represented as purple spheres. Figure 
generated in PyMOL.  
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C.4. Input settings for phenix.autobuild. 
 
Screenshot of input settings for phenix.autobuild used for building the model of CysE. 
C.5. CysE structural files 
Link to google drive folder: 
https://drive.google.com/drive/folders/1lOYqVibWfbxrQQ3OePha1swaKVvIH_2
5?usp=sharing 
C.6. CysE chain statistics 
CysE structure statistics for each monomer in the asymmetric unit. Fold of C-terminal tail is reported 
for each chain. 
Chain Residue chain 
built 
Residues 
missing 
Total built C-terminal tail  
A Asn4-Gln264 11 261/272 Extended 
B Lys3-Gln264 11 261/272 Extended 
C His5-Gln264 17 256/272 Folded 
D Asn4-Ile263 19 253/272 Folded 
E Asn4-Gln264 12 260/272 Extended 
F Lys3-Gln264 12 260/272 Extended 
 
 
 
